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ABSTRACT 
 
Embryo implantation into the endometrium is a complex biological process involving the 
integration of steroid hormone signaling, endometrial tissue remodeling and maternal-
fetal communications. A successful pregnancy is the outcome of the timely integration of 
these events during the early stages of implantation. The involvement of ovarian steroid 
hormones, estrogen (E) and progesterone (P), acting through their cognate receptors, is 
essential for uterine functions during pregnancy. The molecular mechanisms that control 
the process of implantation are undergoing active exploration. Through our recent efforts, 
we identified the transcription factor, CCAAT Enhancer Binding Protein Beta (C/EBP!) 
as a prominent target of estrogen and progesterone signaling in the uterus. The 
development of a C/EBP!-null mouse model, which is infertile, presented us with an 
opportunity to analyze the role of this molecule in uterine function. We discovered that 
C/EBP! functions in two distinct manners: (i) by acting as a mediator of E-induced 
proliferation of the uterine epithelium and (ii) by controlling uterine stromal cell 
differentiation, a process known as decidualization, during pregnancy. My studies have 
delineated important mechanisms by which E regulates C/EBP! expression to induce 
DNA replication and prevent apoptosis of uterine epithelial cells during E-induced 
epithelial growth. In subsequent studies, I analyzed the role of C/EBP! in decidualization 
and uncovered a unique mechanism by which C/EBP! regulates the synthesis of a unique 
laminin-containing extracellular matrix (ECM) that supports stromal cell differentiation 
and embryo invasion. In order to better define the role of laminin in implantation, we 
developed a laminin "1-conditional knockout mouse model. This is currently an area of 
ongoing investigation. The information gained from our analysis of C/EBP! function in 
! """!
the uterus provides new insights into the mechanisms of steroid hormone action during 
early pregnancy. Ultimately, our findings may aid in the understanding of dysregulation 
of hormone-controlled pathways that underlie early pregnancy loss and infertility in 
women.   
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CHAPTER 1 
 
 
 
HORMONAL REGULATION OF UTERINE FUNCTIONS: 
BACKGROUND AND SIGNIFICANCE 1 
 
 
 
1.1. INTRODUCTION 
 
 
Hormonal regulation of growth and proliferation of the endometrium. 
 
The ovarian steroid hormones estrogen (E) and progesterone (P) play critical roles in the 
maintenance of the mammalian uterus through cyclical rounds of cell proliferation and 
differentiation during the reproductive cycle (1). In rodents, ovarian E produced during 
the proestrus stage stimulates uterine luminal and glandular epithelial cell proliferation, 
preparing the uterus for potential pregnancy. During this growth phase, E causes distinct 
physiological changes, such as increased uterine wet weight and structural remodeling of 
the epithelial cell layer, while also accelerating their entry into S-phase of the cell cycle 
(1-4). At the onset of pregnancy, increasing levels of P produced from the newly formed 
corpora lutea in the ovaries suppresses E-stimulated proliferation of the uterine luminal 
epithelium. The actions of E and P in these epithelial cells are mediated via their 
respective nuclear receptors, estrogen receptor alpha (ER!) and progesterone receptor 
(PR) (5, 6). Acting in concert, these hormones control early events that are essential for 
providing a suitable environment for blastocyst attachment to luminal epithelium and 
                                                
1 This chapter was published in Seminars in Reproductive Medicine (2010 Jan; 28(1), 17-26). 
Permission to reprint this article as a Ph.D. dissertation chapter was granted to Cyril Ramathal by 
Thieme Publishers & Seminars in Reproductive Medicine. 
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successful implantation. In the adult female mouse, administration of exogenous E and P 
to ovariectomized mice faithfully reproduces the uterine epithelial responses seen during 
the estrous cycle and early pregnancy. Therefore, the mouse uterine luminal epithelium 
offers as an excellent model in which one may explore the molecular mechanisms by 
which the steroid hormones control cell proliferation. These mechanisms will be 
discussed in more detail in Chapter 2.  
 
Endometrial stromal differentiation and the process of decidualization.  
 
In mammals, the onset of pregnancy is heralded by the implantation of an embryo into 
the uterus, initiating a complex and reciprocal relationship between the mother and the 
fetus. This maternal-fetal dialogue involves an intimate interaction between the 
specialized trophectodermal cells of the embryo and the receptive uterine lining of the 
mother. The steroid hormones estrogen (E) and progesterone (P) play a pivotal role in 
directing early uterine events during pregnancy. These hormones orchestrate the changes 
in the uterine epithelium that makes it competent to attach to the blastocyst and initiate 
the process of implantation (7, 8). Subsequently, E and P regulate a series of complex 
interactions at the interface between the developing embryo and the cells in the stromal 
compartment, leading to the formation of a differentiated maternal tissue, known as the 
“decidua”, which supports embryo growth and maintains early pregnancy. Although the 
details of these events vary in different species, the central roles played by E and P in 
controlling various phases of early pregnancy are common to many mammals (9). 
Ultimately, the timely and ordered regulation of the cellular and genetic changes in the 
 3 
endometrial tissue surrounding the implanting embryo is critical for the establishment of 
early pregnancy. 
 
The mouse blastocyst reaches the uterus four days after fertilization (10, 11). The 
attachment of the blastocyst to the uterine epithelium initiates the process of 
decidualization that involves differentiation of the underlying fibroblastic stromal cells 
into morphologically distinct cells, termed decidual cells (12-14). These differentiated 
cells have unique biosynthetic and secretory properties. There are also substantial 
changes in the extracellular matrix. This cellular differentiation, induced by P following a 
brief priming with E, is a prerequisite for successful implantation. The decidua is a 
transient tissue, which begins to develop at the time of blastocyst attachment on day 4.5 
of pregnancy. During the next 3 days of gestation, decidual cells surrounding the site of 
embryo attachment proliferate and differentiate extensively, eventually becoming larger, 
and often acquire a bi-nucleated or polyploid status (15). Stromal cell polyploidy during 
differentiation eventually results in apoptosis and the latter process is thought to limit the 
life span of decidual cells, allowing placental expansion and development (13, 14). By 
the end of the invasive period (day 10.5), the decidua is totally regressed. A variety of 
functions have been attributed to the decidua, such as providing a source of growth 
factors and cytokines that support embryo development, serving an immunoregulatory 
role during pregnancy and regulating trophoblast invasion (7, 12). An additional role for 
decidual cells is to support maternal blood vessel formation in order to perfuse and 
nourish the developing embryo. Despite these critical functions, steroid-induced signaling 
molecules that participate in the formation and function of the decidual tissue remain 
 4 
poorly understood.  In the next section, we will discuss the role of important steroid-
hormone regulated molecules that have been identified through our efforts and others and 
are involved in early pregnancy by controlling uterine decidualization.  
 
 
Steroid hormone-regulated pathways involved in decidualization and implantation. 
 
 
Role of estrogen and progesterone receptors pathways 
 
Despite the abbreviated reproductive cycle in mice relative to that of humans, this species 
has served as an important animal model to study the regulation of uterine functions by E 
and P. The cellular actions of these hormones are mediated through intracellular estrogen 
receptor (ER) and progesterone receptor (PR) proteins, which are hormone-inducible 
transcription factors (16). Hormone-occupied ER or PR is recruited to specific DNA 
response elements in the promoters of target genes. These genomic actions trigger the 
expression of specific gene networks in different cell types within the uterus and the 
products of these genes in turn mediate the hormonal effects during the reproductive 
cycle and pregnancy. The development of mutant mouse models lacking ER and PR has 
established the requirement of these hormones and their downstream signaling pathways 
for successful establishment and maintenance of pregnancy (5, 6).  
 
The PR knockout (PRKO) mice display a non-receptive uterus that is refractory to an 
artificial deciduogenic stimulus, such as the intrauterine injection of oil (6). Thus, the 
PRKO mouse uterus cannot support embryo implantation. When these mutant mice are 
 5 
placed under chronic E stimulation, increased hyperplasia and an inflammatory response 
is observed, due to unopposed action of E in the uterus (8). On the other hand, ER!-null 
mice have impaired uterine growth and fail to prepare for blastocyst attachment (5). Due 
to the pleiotropic and multisystem effects of global ER! and PR gene ablation, the 
interpretation of the mutant phenotypes is complicated. Thus, we used the LoxP/Cre 
strategy in our recent studies and have uncovered a novel role for ER! in mediating 
stromal cell decidualization (Mary Laws, Indrani Bagchi, and Milan Bagchi, unpublished 
results). Conditional targeting of ER! deletion is achieved through expression of Cre 
recombinase under the control of the endogenous PR promoter, avoiding the embryonic 
and developmental effects of global ER! ablation and allowing significant recombination 
activity only in the PR expressing tissues of the mature animal (17). The ablation of ER! 
in PR-positive uterine cells resulted in a failure of the mutant animals to exhibit a 
decidual response to an artificial stimulus, indicating an important role for ER! in 
decidualization. In summary, mediation of murine endometrial decidualization requires 
ER! and PR proteins to effect uterine stromal differentiation. The current effort in the 
field is to identify and characterize the molecular pathways underlying the actions of E 
and P and their respective receptors.  
 
Downstream mediators of E and P actions during decidualization 
 
A number of studies employing gene expression profiling have identified steroid-
regulated pathways that control epithelial and stromal functions during implantation in 
mice (18, 19). Here, we describe the physiological relevance of three major ER- and PR-
 6 
target genes in embryo implantation and decidualization, with special emphasis on the 
role of the transcription factor C/EBP!, which will be the focus of this dissertation.  
 
Roles of Bone Morphogenetic Protein-2 (BMP2) and Wingless 4 (Wnt4) 
 
BMPs are the largest family of morphogens belonging to the TGF-! superfamily of 
growth modulators. They were initially identified by their ability to induce ectopic 
formation of cartilage and bone, and were subsequently shown to influence a broad 
spectrum of cellular functions including proliferation, differentiation, apoptosis, 
migration, and adhesion in a large variety of cell types during embryonic development 
(20). Recently, the decidual stage-specific expression of BMP2 and its receptor in the 
uterine stroma during early pregnancy was uncovered, providing a potential link between 
BMP2 signaling and the steroid-dependent changes underlying stromal differentiation 
during decidualization (21).  
 
BMP2 is expressed in the stromal cells surrounding the implanted embryo (22). Studies 
by S.K. Dey and coworkers demonstrated that when beads coated with heparin-binding 
epidermal growth factor were placed into pseudopregnant uteri, they induced 
decidualization concomitantly with BMP2 expression (23). Administration of the 
antiprogestin RU486 downregulated BMP2 expression in uterine stromal cells, indicating 
that the expression of BMP2 is downstream of pathways mediated via PR (24). The 
functional role of BMP2 during embryo implantation was demonstrated using transgenic 
mice carrying a conditional deletion of this gene in mouse uterus (22). BMP2-null mice 
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are infertile due to the absence of a decidual response. Although the embryos attach to the 
uterine epithelium, the stromal cells fail to undergo decidualization. The decidual 
phenotype could be partially rescued through the addition of recombinant BMP2 into the 
uterine lumen, ruling out the possibility that a developmental defect contributes to the 
implantation failure.  
 
In parallel with the creation of the BMP2-null mice, mouse primary stromal cultures were 
utilized to provide novel insights into the role of BMP2 and its downstream signaling 
pathways in uterine decidualization (24). The addition of recombinant BMP2 to the 
undifferentiated mESC significantly increased Smad signaling which in turn led to an 
increase in ALP activity and markedly accelerated the stromal differentiation program. 
Furthermore, when an siRNA targeted to BMP2 mRNA was transfected into 
undifferentiated mESCs, it efficiently suppressed BMP2 expression and also inhibited 
stromal differentiation as indicated by the drastically reduced expression of the well-
established decidual markers. These studies indicated that BMP2-mediated canonical 
Smad signaling in the uterus plays a critical role in stromal cell differentiation during 
early pregnancy.  
 
Microarray analyses conducted with BMP2-null mESCs revealed the involvement of 
Wnt4 in BMP2 signaling (24). The Wnt family of signaling proteins exerts pleiotropic 
effects similar to Bmp2 (25). Overlapping expression of BMP2 and Wnt4 was noted in 
vivo in the uterine stromal compartment during early pregnancy (23). Most importantly, a 
marked induction of Wnt4 in mESC cultures was observed when Bmp2 was added to 
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induce differentiation, suggesting that it is a direct downstream target of Bmp2 action 
(24). 
  
Roles of Indian Hedghog (Ihh) and COUP-TFII 
 
Studies by DeMayo and coworkers revealed a novel role for another morphogen, Indian 
Hedgehog (Ihh), in mediating epithelial and stromal cross-talk that triggers 
decidualization. The regulation of this factor by P and PR appears to be confined to the 
luminal epithelium of the receptive uterus during the window of implantation (26, 27). 
The expression of Patched-1 (Ptch1), the receptor for Ihh, exhibited a similar temporal 
pattern in the stromal compartment, supporting an epithelial-stromal communication. 
Conditional ablation of Ihh expression in the uterus yielded reproductive defects that are 
consistent with a role for epithelial Ihh in mediating PR-controlled decidualization of the 
subjacent stroma (28). Recent studies using tissue recombinants indicated that the 
expression of Ihh in the epithelium is controlled by stromal PR (29), indicating complex 
interactions between epithelial and stromal compartments that require further exploration.  
 
Prominent among the potential target genes mediating Ihh function in the uterine stromal 
cells is the orphan nuclear receptor family member COUP-TFII. Insights into the 
reproductive functions of COUP-TFII were gained by Cre recombinase-mediated 
conditional excision of this gene in mouse uterus (30). The loss of COUP-TFII in the 
uteri rendered these mice infertile primarily due to a loss of embryo attachment in the 
luminal epithelium. Furthermore, a failure of the artificially induced decidual reaction 
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revealed a stromal impairment. Interestingly, administration of recombinant BMP2 in 
vivo led to a partial rescue of the decidualization phenotype in COUP-TFII-null uteri, 
indicating that BMP2 is a downstream mediator of COUP-TFII function (30). 
Collectively, these findings broadly defined a dynamic pathway in which PR regulates 
epithelial Ihh expression and secretion into the stromal compartment. Ihh then acts via the 
Ptch1 receptor to induce a decidual response, which is mediated by COUP-TFII and 
BMP2.  
 
Identification of (C/EBP!) as a novel target of steroid regulation during implantation 
 
Gene expression profiling conducted in our laboratory identified CCAAT/Enhancer 
Binding Protein-! (C/EBP!) as a novel target of E and P actions in the mouse 
endometrium (18, 31, 32). This transcription factor belongs to a family of basic leucine 
zipper (bZIP) proteins, which regulate numerous biological processes, including cell 
proliferation, differentiation, metabolic homeostasis, acute phase inflammation and 
apoptosis (33). While C/EBP! has been shown to be a critical regulator of proliferation in 
mammary gland (34, 35), liver (36) and now uterine epithelium (37), this molecule has 
also been linked to anti-proliferative actions in separate tissues, such as epidermal 
keratinocytes (54). This suggests that C/EBP! can exert both positive and negative 
control of the cell cycle and its function is dependant on the cellular environment.  
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Role of C/EBP! in the mouse endometrium during implantation 
 
Among the C/EBPs, C/EBP! has been identified as a critical mediator of the biological 
actions of E and P in mouse uterus (32). The administration of E or P to ovariectomized, 
non-pregnant mice caused a robust induction of C/EBP! mRNA and protein expression 
in both epithelial and stromal compartments (32). During normal murine pregnancy, a 
robust induction of C/EBP! occurs predominantly in the stromal compartment during the 
decidualization phase. Similarly, C/EBP! expression is up regulated upon experimentally 
induced decidualization. The decidual stage-specific expression of C/EBP! likely arises 
from a complex interplay of E and P within the uterine compartments. Although a 
transient rise in E in the preimplantation period induces C/EBP! in the stromal 
compartment of pregnant uterus, PR becomes a critical regulator of this gene as these 
cells become progressively differentiated. This view is strongly supported by the 
observation that RU486, an antagonist of PR, efficiently suppressed stromal C/EBP! 
expression when administered on day 6 of pregnancy (32). 
 
The essential role for C/EBP! in decidualization was uncovered when mice carrying a 
deletion in this gene were examined. Peter Johnson and coworkers first reported that 
female mice lacking C/EBP!  were infertile, due to complications in ovulation (39). 
However, upon further examination, functional abnormalities in the uterus also were 
evident in mutant females (32). Wild-type (WT) embryos transferred to pseudopregnant 
uteri of C/EBP!-null mice failed to implant. Uterine defects noted in the mutant mice 
included a reduced epithelial cell proliferation in response to E, and more importantly, an 
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impaired stromal response to a deciduogenic stimulus. There was a striking lack of 
expression of alkaline phosphatase (ALP), a classical early marker of stromal cell 
differentiation, in C/EBP!-null stroma. These phenotypic defects were observed in the 
presence of exogenously administered E and P, indicating that they were independent of 
ovarian malfunction, and intrinsic to the uterus.  
 
In addition to its role in decidualization of the uterus, C/EBP! appears to be important for 
the proliferation of the stromal fibroblasts, an event that precedes their differentiation to 
decidual cells. The morphology of C/EBP!-null uteri in response to a decidual stimulus 
showed a significantly reduced mass of stromal cells as compared to WT uteri, indicating 
that stromal cells were not proliferating efficiently in the mutant. This was evidenced by 
a drastic reduction in Ki67 staining at 24 h following a decidual stimulus (32). Further 
investigation of this observation revealed that DNA synthesis was intact in the mutant 
stromal cells but they are eventually arrested at the G2-M checkpoint (Wang, W. et. al, 
unpublished). This is supported by microarray analysis, where the expression of cyclins 
B1 and B2 and two other G2-M regulators, E2F3 and 14-3-3 zeta is downregulated in 
C/EBP!-null stroma.  
 
 
C/EBP! is a critical regulator of decidualization in the mouse endometrium 
 
 
The expression pattern of C/EBP! closely overlaps with the onset of decidualization 
during implantation. Additionally, mice nullizygous for C/EBP! are infertile (32, 39). To 
investigate whether the mutant mice could support pregnancy, Mantena et al performed 
 12 
embryo-transfer experiments. In these experiments, blastocysts were harvested from WT 
females on day 4 of pregnancy and were subsequently placed into the uteri of 
pseudopregnant WT or C/EBP!-null females, on day 4 of pseudopregnancy. After a 
period of five days, the number of implanted embryos and the size of the decidual tissue 
were assessed. It was found that a substantial number of blastocysts did not implant into 
the C/EBP!-null recipients (>90%) and there was a remarkable lack of decidual mass 
formed in the mutant (32). These findings indicated a fundamental defect in uterine 
function during pregnancy.  
 
To address whether this defect could be a result of inadequate steroid hormone levels 
synthesized by the ovary, E and P were administered to C/EBP!-null mice and a artificial 
decidual stimulus given. In this protocol, WT and C/EBP!-null mice are ovariectomized, 
treated with E and P and then decidualization is experimentally induced with mechanical 
stimulation of the uterus (18, 32). When the uterine horns were examined within 72 h 
after receiving a stimulus, the WT mice displayed a robust decidual response, evidenced 
by an enlarged horn packed with decidual cells (32). In contrast, the similarly treated 
C/EBP!-null uterine horns showed a significantly reduced mass of decidual cells. Further 
analysis was conducted using well-established biochemical markers of decidualization. 
The expression of one such marker, alkaline phosphatase (ALP), was markedly 
diminished in the C/EBP!-null uteri 72 h after artificial decidual stimulation (32). 
Meanwhile, the levels of ER" and PR remained unchanged between WT and mutant 
uteri, indicating that steroid hormone signaling pathways were not disrupted. 
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Collectively, these observations highlight the important role of C/EBP! in 
decidualization and implantation. 
 
Gene networks downstream of C/EBP! involved in decidualization: modulation of 
extracellular matrix (ECM) 
 
The striking defect in decidualization witnessed in C/EBP!-null mice prompted the 
examination of gene networks that might be regulated by this transcription factor in the 
endometrium. Using a DNA microarray approach, we were able to identify putative 
targets of C/EBP! action in purified uterine stromal cells isolated from WT and C/EBP!-
null mice. There were several prominent categories of genes uncovered from this 
analysis, among which there was one class of genes encoding molecules involved in the 
formation of the extracellular matrix (ECM) (Wang, W. et. al, unpublished). The 
extracellular matrix is a complex and dynamic structure that controls cell function by 
regulating the interactions between cells and their substrates and modulating external 
stimuli such as growth factors and cytokines (40). The most significantly regulated ECM-
related molecules in our analysis included hyaluronan synthase I, which synthesizes 
hyaluronic acid, and two proteins that function in partnership with the hyaluronan 
network, Ptx3 and Tnfip6 (41-43). More interestingly, a group of ECM molecules 
involved in basement membrane-like matrix formation were identified by our gene 
profiling studies, namely, collagen type IV "2 subunit, laminin subunits "1 and #1 and 
fibulins 1 and 2. These molecules assemble together to form a classical basement 
membrane or basal lamina-like structure, which then recruits other ECM proteins such as 
nidogen, fibronectin and entactin. The integrity of this multi-molecular structure depends 
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on the self-polymerization of laminin subunits and the subsequent binding interactions 
between these laminins and other ECM molecules (40, 44-47). The potential regulation of 
this unique ECM by C/EBP! is intriguing for two major reasons. Firstly, the observations 
that notable basal lamina components were being synthesized in the uterine stoma, a non-
classical basal lamina setting, are counter-intuitive to current concepts about ECM 
function. Secondly, there are previous reports of basement membrane proteins, such as 
laminins and collagen type IV, being robustly expressed in decidual tissue during 
implantation (48, 49). Collectively, these findings raise the possibility that the C/EBP!-
regulated ECM molecules participate in the formation of a unique basement membrane-
like environment that supports decidualization and pregnancy in the mouse. The 
availability of a powerful in vitro primary culture system in which we can differentiate 
uterine stromal cells to decidual cells presented us with an opportunity to address the 
above hypothesis. This work will be discussed in Chapter 3. Furthermore, in Chapter 4, 
we describe ongoing studies in which we created a conditional laminin !1 knockout 
mouse using a loxP/Cre strategy to evade the embryonic and developmental effects of 
global laminin !1 ablation.  
 
Conclusions 
 
The involvement of steroid hormones E and P acting through their cognate receptors is 
critical to the precise and timely regulation of the endometrial events required for 
pregnancy. These events comprising embryo attachment, stromal decidualization and 
vascularization of the endometrium require the appropriate participation of a host of 
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genes that are regulated by E and P (Fig. 1.1). This chapter has focused on the theme of 
decidualization as a biological event that is both unique and essential to pregnancy in 
mice and humans. The use of powerful mouse genetics and manipulation of mouse 
culture systems, combined with informative gene expression profiling strategies in 
murine samples, has made it feasible to pinpoint specific molecular cues to 
decidualization. Our studies have centered on the role of one such molecule, C/EBP!, as 
an important regulator of uterine functions. These and future studies will serve to 
illuminate the mechanisms by which E and P regulate uterine function and will serve as a 
framework in which to explore new therapeutic approaches to human endometrial 
diseases, particularly those associated with aberrant steroid hormone signaling such as 
excessive E action or reduced P sensitivity.  
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1.2. FIGURES AND LEGENDS 
 
FIG. 1.1. 
  
  
Figure 1.1.  The molecular pathways controlling decidualization 
 
An emerging blueprint of the molecular pathways underlying the mouse and human 
endometrial functions, leading to decidualization, is shown. EPI and STR represent 
uterine epithelial and stromal compartments, respectively. The bold arrows represent the 
hypothetical linear relationships between the indicated factors. The dashed arrows point 
to functional links for which the mechanisms are still unknown. The schematic describes 
only those factors that are discussed in this article. BMP2, bone morphogenetic protein 
2; cAMP, cyclic adenosine monophosphate; C/EBP!, factor CCAAT/enhancer binding 
protein-!; COUP-TF II, chicken ovalbumin upstream promoter-transcription factor II; 
Cx43, connexin 43; E, estrogen; ER", estrogen receptor "; FoxO1, Forkhead Box O1; 
Hoxa-10, Homeobox A10; Ihh, Indian hedgehog; IL, interleukin; IL11R", interleukin 11 
receptor "; PR, progesterone receptor; VEGF, vascular endothelial growth factor; Wnt4, 
Wingless 4. 
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CHAPTER 2 
 
 
 
C/EBP!  IS AN ESSENTIAL MEDIATOR OF ESTROGEN-INDUCED 
PROLIFERATION OF THE UTERINE EPITHELIUM 1 
 
 
2.1. ABSTRACT 
 
 
Female mice lacking the transcription factor C/EBP! are infertile and display markedly 
reduced estrogen (E)-induced proliferation of the uterine epithelial lining during the 
reproductive cycle. The present study showed that the E-stimulated luminal epithelial 
cells of C/EBP!-null uterus are able to proceed through the G1 phase of the cell cycle 
before arrest in the S phase. Markedly reduced expression of E2F3, an E2F family 
member, and lack of nuclear localization of cyclin E, a critical regulator of cdk2, 
accompanied this cell-cycle arrest. An increased nuclear accumulation of p27, an 
inhibitor of the  cyclin E/cdk2 complex, was also observed in the mutant epithelium. 
Gene expression profiling of C/EBP!-null uterine epithelium revealed that the 
blockade  of  E-induced  DNA  replication  triggers  the  activation  of  several  well-
known components of DNA damage response pathway, such as ATM, ATR, histone 
H2AX, checkpoint kinase 1 and tumor suppressor p53. Activation of p53 by 
ATM/ATR kinase led to increased expression of p21, an inhibitor of G1-S progression, 
which helps maintain the cell-cycle arrest. Additionally, p53-dependent mechanisms 
                                                
1 This chapter was published in Molecular and Cellular Biology (Ramathal, C. R., Bagchi, I. C. 
and Bagchi, M. K. (2010) Mol. Cell Biol.). Permission to reprint this article as a Ph.D. 
dissertation chapter was granted to Cyril Ramathal by the American Society for Microbiology 
(ASM) Journals Department.  
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contributed to an increased apoptosis of replication-defective cells in the C/EBP!-null 
epithelium. C/EBP!, therefore, is an essential mediator of E-induced growth and 
survival of uterine epithelium of the cycling mice. 
 
 
2.2. INTRODUCTION 
 
The physiology of estrogen-induced uterine epithelial proliferation 
 
In preparation for pregnancy, the uterine epithelium of the adult cycling mouse undergoes 
several synchronized rounds of cell proliferation (1). Ovarian estrogen (E) and 
progesterone (P) production regulate this cell proliferation process in a carefully 
controlled manner, allowing for appropriate uterine growth. Rising E levels during the 
proestrus stage of the reproductive cycle stimulate uterine epithelial cells to undergo 
DNA replication, resulting in the overall growth of the epithelial lining (1-4). At the onset 
of pregnancy, increasing production of P from the ovary inhibits E-induced epithelial 
proliferation. The dynamic actions of these two hormones in the uterine epithelium are 
mediated via their cellular receptors, estrogen receptor " (ER") and progesterone 
receptor (PR) (5, 6). As a result of the dynamic interplay between E and P, the uterine 
epithelium is well prepared for the arrival of a blastocyst. The use of ovariectomized 
mice, which have been administered exogenous E and P, presents a valuable model with 
which to explore the molecular regulation of uterine epithelial proliferation.  
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The mechanisms of estrogen-regulated proliferation in the endometrium 
 
Several previous studies documented the mitogenic effects of E on rodent uterine 
epithelium and examined the mechanisms underlying this steroid-stimulated proliferation 
(1, 4). The administration of E to ovariectomized mice led to transcriptional induction of 
proto-oncogenes such as c-fos, c-myc, and n-myc, the epidermal growth factor (EGF) and 
its receptor EGFR, transforming growth factor (TGF) !, and insulin-like growth factor 1 
(IGF-1), concomitant with uterine epithelial proliferation (1, 4, 7, 8). Based on these 
findings, it was proposed that proto-oncogene and growth factor pathways mediate E-
induced growth response in the uterus (9-12). However, later studies using knockout 
mouse models failed to provide unequivocal evidence in support of a role of certain of 
these factors in the female reproductive tract (13, 14). For example, the EGF-null mice 
exhibited no reproductive abnormalities, suggesting that E-mediated growth of the 
uterine epithelium is not completely abrogated in these mice (13). Similarly, mice lacking 
TGF! did not display any reproductive deficiency (14). Interestingly, administration of P 
to ovariectomized mice, which down-regulated E-induced uterine epithelial proliferation, 
did not alter the expression profiles of many of these growth-promoting factors, 
indicating that these factors may not directly participate in E-induced cell cycle entry. 
Collectively, these observations raised the possibility that additional factors are involved 
in transmitting the E-induced growth response to the cell cycle machinery (1, 9, 12). 
 
In recent studies, we identified and characterized the transcription factor, CCAAT 
Enhancer Binding Protein Beta (C/EBP") as a steroid-hormone regulated gene that is 
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critical for uterine functions (15). C/EBP! is a member of the bZIP family of leucine-
zipper proteins and has been implicated as a regulator of proliferation and differentiation 
in a diverse set of tissues (16-20). The importance of C/EBP! in female fertility was 
revealed when the C/EBP!-null females were found to have severely compromised 
ovarian and uterine functions. In addition to a failure in ovarian follicle rupture (21), the 
C/EBP!-null uterus is refractory to embryo attachment to uterine luminal epithelium 
(LE), as demonstrated by embryo transfer experiments performed in ovariectomized mice 
supplemented with E and P (15). The expression of C/EBP! is induced rapidly in the 
uterine LE during the early phases of E-induced proliferation of this tissue (15). Its 
importance in uterine growth was highlighted by the markedly diminished expression of 
the Ki67 antigen, a widely used marker of cell proliferation, in E-treated uterine epithelia 
of C/EBP!-null mice (15).  
 
In this study, we noted that simultaneous treatment with P, which reduces E-induced 
uterine LE proliferation, also decreased the expression of C/EBP!, thereby positioning 
this transcription factor as a biologically relevant mediator of E action in this tissue. We 
postulated that E-induced expression of C/EBP! and its downstream targets control the 
production and/or activity of one or more major cell-cycle regulatory molecules in the 
uterine epithelium. Using stage-specific cell-cycle markers, we determined that the loss 
of C/EBP! leads to a significant impairment in DNA replication in the uterine LE. We 
also identified alterations in the expression and cellular localization of cyclin E, E2F3, 
and p27, key molecules that modulate the G1-S transition of the cell cycle. We further 
showed that the proliferation defect in C/EBP!-null uterine LE is associated with the 
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activation of well-known DNA damage response pathways involving ataxia 
telengiectasia mutated (ATM), ATM-Rad3-related (ATR), checkpoint kinases Chk1/2, 
and p53. The activated p53 helps to maintain the G1-S blockade of the cell cycle by 
inducing the synthesis of the inhibitor p21. P53 also promotes apoptosis of replication-
defective uterine LE cells. Collectively, these studies identified the molecular pathways 
by which C/EBP! mediates E-induced proliferation and survival of uterine LE during the 
reproductive cycle and early pregnancy.   
 
 
 
2.3. MATERIALS AND METHODS 
 
 
Animals, hormone treatments and tissue collection. 
 
All experiments involving animals were conducted in accordance with the National 
Institutes of Health standards for the use and care of animals. The animal protocols 
were approved by the University of Illinois Institutional Animal Care and Use 
Committee. Heterozygous mice carrying a mutation in C/EBP! gene were provided by 
Dr. Peter F. Johnson of the National Cancer Institute. Female mice  carrying  a  null  
mutation  in  the  C/EBP!  gene  were  derived  from  crosses  of heterozygous females 
with nullizygous male mice as described previously (21). Female WT and C/EBP!-null 
mice of 129Sv background were ovariectomized at 10-11 weeks of age and rested for 
two weeks. These mice were then treated with a single dose of E (250 ng in sesame 
oil) by intraperitoneal injection (i.p.) for various durations. In experiments where P was 
used, mice were injected with a single dose of P (1 mg in sesame oil) along with E (250 
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ng). For each treatment group, at least five mice were used at each time point. In some 
experiments, animals were injected i.p. with BrdU (2 mg/animal; BD Pharmingen) 1  
h prior to sacrifice. Uteri were collected and fixed in 10% formalin prior to 
immunohistochemistry (IHC). Alternatively, uteri were pooled for isolation of primary 
epithelial cells. 
 
Isolation of mouse primary uterine epithelial cells 
 
Hormone-treated uterine horns were excised, trimmed of fat and dissected 
longitudinally to expose the uterine lumen. Dissected horns were then cut into 4 to 5 
mm long pieces and washed in Hank’s Balanced Salt Solution (HBSS; Gibco). Uterine 
tissue pieces were then placed in HBSS containing 6 g/L dispase (Invitrogen) and 25 
g/L pancreatin (Sigma) for 1 h at RT followed by 10 min at 37 ºC. The tubes were 
gently agitated to release luminal epithelial cells from the rest of the uterine tissue. The 
cell suspension was filtered through a 100 !m pore-size sieve (BD) to remove any 
tissue debris. The filtrates containing luminal epithelial cells were centrifuged at 2000 
rpm for 5 min to pellet the cells. The cells were washed twice in PBS and re-pelleted. 
The pellets were lysed with Trizol for RNA extraction or with RIPA lysis buffer for 
preparation of whole cell protein lysates. 
 
Real-time PCR analysis 
 
Total RNA was isolated from uterine cells by standard Trizol-based protocols and 
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converted to cDNA. The cDNA was amplified by real-time PCR to quantify gene 
expression using gene-specific primers and SYBR® Green (Bio-Rad Laboratories) in 
an iCycler (BioRad) instrument. As a loading control, the expression level of the 36B4 
gene, which encodes a ribosomal protein, was determined. For each treatment, the mean 
threshold cycle (Ct) and standard deviation were calculated from Ct values obtained 
individually from 3 to 4 replicates of that sample. Each sample was subjected to three 
independent real-time PCR trials. Normalized Ct (!Ct) values were determined by 
subtracting the mean Ct values of 36B4 from the mean Ct of each gene. The 
!!Ct values were then calculated as the differences between !Ct values of 
genes from treated samples and control samples. Fold change was derived by 
applying the formula 2-!!Ct to the !!Ct values. The error bars indicate 2-
!!Ct ± S.D. ANOVA single factor analysis was conducted on the grouped means to 
determine statistical significance at a significance level of P<0.05. 
 
The real-time PCR primer sequences are: C/EBP", AGCGACCAGTACAAGATG 
(forward) and CTGCTCCACCTTCTT (reverse); cyclin E, 
CCTGGATGTTGGCTGCTTAG (forward) and CACCACTGATAACCTGAGACC 
(reverse); cyclin D1, GCATCTACACTGACAACTCTATC (forward) and 
GCCAGGTTCCACTTGAGC (reverse); cyclin A, TCTTCCTTCCTTGGTTGCTG 
(forward) and ACTTCTCCCTGATTGCTTGC (reverse); cyclin B, 
CATTCCAAGTTTCGGCTTCT (forward) and CGTCAGCTCCATCAGGTCATT 
(reverse); E2F1, GTACTCCAGCCGCATGTATC (forward) and 
GCCATAGGAAGGACGCATAC (reverse); E2F2, GGCAACTTCAAGGAGCAGAC 
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(forward) and GGCACAGGTAGACTTCAATGG (reverse); E2F3, 
GAACAAGGCAGCAGAGGTG (forward) and GACTTCTTCTTAATGAGGTGGATG 
(reverse); cdk2, ACAGGGCAAGGTGAAAGAC (forward) and 
AGGAGGACGGCAATGAGG (reverse); cdk4, TTGCCTCCAGAAGACGAC (forward) 
and GCTCCAGACTCCTCCATC (reverse); cdk1, CTGGGCACTCCTAACAACGAAG 
(forward) and TCCAAGCCGTTCTCGTCCAG (reverse); Lactoferrin, 
GGACCGCAGGCTGGAACATC (forward) and 
ACAGGGCACAGAGATTGGATTTGG (reverse); p27, 
GTTGCTTTGTGTGGCTTCTG (forward) and TGGTTGCTTGGCTAATAAATGC 
(reverse); p21, GTTCCTTGCCACTTCTTAC (forward) and 
ACTGCTTCACTGTCATCC (reverse); 36B4, CTGCTGCCACCACTGCTG (forward) 
and TCCTCATCTGATTCCTCCGACTC (reverse); ATM, 
CCAGCATCTCCTCCTCCAC (forward) and CGCACCACTCTCGTCTTTC (reverse);  
 
DNA microarray analysis 
 
WT and C/EBP!-null mice were ovariectomized and treated with E, and after 18 h, the 
LE cell layer was isolated and total RNA was prepared using Trizol-based protocols. 
Total RNA was incubated with DNase I (DNA-free ®, Ambion Inc.) to eliminate 
genomic DNA contamination. RNA concentration and purity were assessed by 
measuring the A260/280 OD ratios in a spectrophotometer. The integrity of 
the RNA samples was analyzed by using a Bio-Analyzer gel electrophoresis 
method to distinguish bands of 18S and 28S ribosomal RNA. The RNA was 
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then processed to generate biotinylated cRNA probes that were subsequently 
hybridized to high-density Affymetrix oligonucleotide arrays (GeneChip®Mouse 
Genome 430 2.0 Array) representing ~14,000 known murine genes. Fluorescent 
hybridization signals from the arrays were analyzed by GeneChip® Scanner® 3000 
and data files processed for comparison analysis using GeneChip® Operating 
Software (GCOS). The hybridization signals were analyzed by comparing arrays 
hybridized with WT and C/EBP!-null epithelial RNA samples, respectively, using the 
WT signals as a baseline. Using the signal-log ratios for each gene, the fold change in the 
expression of that gene was determined. Finally, the comparison analysis yielded a list of 
genes that were upregulated (+) or downregulated (-) in C/EBP!-null uterine epithelium 
relative to WT samples.  
Potential C/EBP!-regulated genes obtained from microarray analysis were further 
categorized by biological functions using two major gene ontology softwares: Panther 
(http://www.pantherdb.org) and Ingenuity Pathway Analysis (Ingenuity ® Systems).  
 
Immunohistochemistry (IHC) 
 
Formalin-fixed uterine pieces were processed for paraffin embedding. Cross sections 
(5 !m thickness) were mounted onto microscope slides (Fisher Scientific). For 
immunostaining, uterine sections were deparaffinized in xylene (thrice, 5 min each), 
rehydrated through a graded series of treatment with ethanol (100%, 95%, 85%, and 
70%, 5 min each) and rinsed in tap water. For all samples, antigen retrieval was 
performed by boiling the sections in 0.01 M sodium citrate buffer (pH 6.0) for 20 min, 
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followed by incubation at RT for 30 min. A 5% solution of normal donkey serum 
(Jackson Immunoresearch) in PBS was used as a blocking buffer. Sections were 
incubated with the following primary antibodies diluted in blocking solution (0.25% 
BSA, 0.3% Triton X-100, sterile PBS) overnight at 4ºC: BrdU & Ki67 (BD 
Pharmingen), phospho-Ser10 histone H3  (Upstate  Biotechnology),  cyclin  E,  cyclin  
A  &  Rad18  (Abcam),  cyclin  D1 (LabVision NeoMarkers), E2F-3 (Santa Cruz 
Biotechnology), p27 (BD Transduction Laboratories), phospho-(Ser1981)-ATM,   
phospho-(Ser139)-H2AX,   Caspase   3   &   cleaved Caspase  3  (Cell  Signaling  
Technology).  The sections  were  washed  and  incubated  with biotinylated 
secondary  antibodies  (Jackson  Immunoresearch  Laboratories  Inc.)  for  60  min 
followed  by incubation  with  streptavidin-conjugated  horseradish  peroxidase  
(Histostain  Kit; Zymed  Laboratories Inc.)  for  45  min. Sections  were  stained  with  
AEC  solution  (Zymed Laboratories Inc.) and counterstained with Mayer’s 
Hematoxylin (Sigma). Immunofluorescence staining was performed by incubating 
sections with the Cy3-conjugated Streptavidin complex (Jackson Immunoresearch 
Laboratories) following incubation with secondary antibodies. The counterstaining was 
done using 4’,6’-diamidino-2-phenylindole (DAPI; Invitrogen Inc.). Stained sections 
were mounted in fluorescence mounting media (20% Glycerol, 8% w/v Poly-vinyl 
alcohol  (PVA),  Diazabicyclo  [2.2.2]  octane  (DABCO),  Tris-HCl  pH  8.5  and  sterile  
water). Negative controls included incubation with donkey serum and omission of the 
primary antibody for all samples. 
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TUNEL staining 
 
To detect apoptotic cells containing fragmented DNA, in situ labeling of free 3’ OH of 
nicked DNA was carried out, using the In Situ Cell Death Detection Kit (Roche 
Applied Science), following the manufacturer’s  protocol.  Briefly,  deparaffinized  and  
rehydrated  sections  were incubated at RT for 15 min with proteinase K (20 !g/mL in 
10 mM Tris-HCl, pH 8.0). Sections were washed and incubated for 1 h at 37ºC in the 
TUNEL reaction mixture containing terminal deoxynucleotidyl transferase enzyme 
(TdT), fluorescein-labeled nucleotide mixture and diluent buffer (30 mM Tris-HCl, pH 
8.0). For negative controls, TdT enzyme was omitted from the reaction mixture. 
After rinsing in PBS, sections were counterstained with DAPI and mounted in 
fluorescence mounting media. 
 
Image capture and quantitation of immunostaining 
 
The images of immunohistochemical staining were captured using a Leica (Nussloch, 
Germany) DM2500 light microscope fitted with a Qimaging Retiga 2000R camera 
(Qimaging, British Columbia, Canada). For counting, at least 5-6 individual 40x 
fields from each sample were captured. The number of positively stained uterine LE 
nuclei in each field were averaged and expressed as a percentage of the total number of 
these cells. The standard deviation was determined for each averaged total. ANOVA 
single factor analysis was conducted on the grouped means to determine statistical 
significance at a significance of P<0.05. Fluorescent images for phospho-histone H3, 
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cyclin E, p27 and E2F-3 were captured using the Leica DM2500. For all other 
antibodies, fluorescence microscopy and image capture were performed using a 
Leica DMR microscope and a Retiga EXI monochrome CCD camera (Qimaging). All 
images were processed using Adobe Photoshop CS version 8.0. 
 
Western Blotting 
 
Whole cell lysates were prepared from primary LE cells isolated from uteri 
collected from control (untreated) or E-treated WT and C/EBP!-null mice. The cells 
were homogenized using a RIPA lysis buffer. Protein concentrations of cell lysates 
were determined using the Bradford assay from  Bio-Rad.  Proteins in 20  !g  of  each  
cell  lysate  was  separated  by  SDS-PAGE  (10%)  and transferred to  Hybond-P 
membranes  (Amersham Pharmacia Biotech).  The membranes were blocked in Tris-
buffered saline with 0.1% (v/v) Tween-20 (TBS-T) and 5% (w/v) nonfat dry milk for 
1 h. They were then incubated overnight at 4ºC with primary antibodies diluted 1:1000 
in  TBS-T  containing  5%  (w/v)  BSA.  These antibodies  were  directed  against  
Chk1,  p53, phospho-Thr187-p27 and calnexin (Santa Cruz Biotechnology), p21 (BD 
Pharmingen), phospho-Ser296-Chk1 and phospho-Ser15-p53 (Cell Signaling Technology) 
and cdk2 and phospho-Thr160-cdk2 (Abcam). Membranes were then incubated for 1 h at 
RT with secondary antibodies conjugated to horseradish peroxidase and diluted 1:5000. 
After thorough washes with TBS-T, chemiluminescence detection was performed 
using SuperSignal Femto and Pico reagents from Pierce (Thermo Scientific). 
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Chromatin Immunoprecipitation (ChIP) 
 
The ChIP analysis was conducted using the EZ-ChIP (Upstate Biotechnology), 
according to the manufacturer’s protocol.  Briefly, mouse uterine LE  cells  were  
isolated  from  11-week  old, ovariectomized WT mice of 129sv background that were 
subjected to E treatment (250 ng) for 12h. The cells (7.5 x 106) were washed in PBS 
and cross-linked with 1% formaldehyde at room temperature for 10 min. The cross-
linked cells were lysed using SDS lysis buffer and sonicated 5 times for 10 sec each 
pulse. Lysates were precleared with salmon sperm DNA-protein A and the DNA-protein 
complexes were subsequently immunoprecipitated using antibodies against RNA 
polymerase II, rabbit IgG or C/EBP! (Santa Cruz Biotechnology). The immune 
complexes were recovered with protein A  agarose.  The beads were then  repeatedly  
washed  and  protein complexes were eluted. The cross-linking was reversed and 
proteins were digested using 0.5 mg/ml proteinase K. Purified DNA were used as 
templates for real-time PCR using various primer sets to amplify specific regions of the 
E2F3 promoter. 
 
In silico Promoter Analysis 
 
Putative C/EBP! binding sites at the E2F3 promoter were determined by in silico 
analysis of the proximal promoter region (-1 bp to -1900 bp) using TESS (22), TFsearch 
(23) and Consite (24) softwares.  Primers were designed  to  amplify  specific  regions  
containing  putative  C/EBP! binding sites as follows: -329 bp to -340 bp 
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(TTCATACCCCTCCCACAAGA & TTTTATTGTCCTTCTAGCCATGA); -458bp to -
473 bp (CCAGTGATTCAGCATACATTACA & TTATTGCCCTCACCACCTTC); 
-584 bp to -595 bp (ACAGTCTTGGGTGAGCTGGT & CCCTACACACTCGGTTCCT) 
and -1054 bp to -1066 bp (AGCCTCTTTGACTGGGACTG & 
TCAGTATTTTGCTGGGGTCTC). 
 
Statistical Analysis: 
 
Statistical significance was assessed by ANOVA analysis at a significance level of P < 
0.05 and is indicated by an asterisk in the figures. NS indicates non-significant changes (P 
> 0.05). 
 
 
 
 
2.4. RESULTS 
 
P suppresses E-induced C/EBP!  expression in uterine epithelial cells 
 
It is well known that P antagonizes the E-induced proliferation of uterine LE cells (1, 25, 
26). Our previous studies showed that C/EBP! expression is markedly induced in the 
uterine LE of ovariectomized mice in response to an acute administration of E (15). We 
report here that simultaneous administration of P inhibited acute E-induced uterine LE 
proliferation as measured by Ki67 immunostaining (Fig. 2.1, A). We also determined the 
levels of C/EBP! mRNA and protein in uterine LE cells of ovariectomized mice after 
treatment with E or E plus P for 2 and 11 h. We noted that treatment with E alone leads to 
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a robust increase in C/EBP! mRNA and protein levels within 2 h followed by a decline 
in its expression to basal levels by 11 h (Fig 2.1, B and C). When mice were treated with 
a combination of E and P, the E-induced increase in C/EBP! mRNA levels at 2 h was 
strongly suppressed. P, therefore, counteracts the transcriptional induction of C/EBP! by 
E. These results are consistent with our hypothesis that C/EBP! is a critical downstream 
mediator of E-stimulated uterine epithelial cell proliferation and P exerts its 
antiproliferative effects, at least in part, by suppressing C/EBP! expression in these cells. 
 
E-dependant S-phase activity is impaired in C/EBP!-null uterine epithelium 
 
Earlier studies demonstrated that E-induced proliferation of uterine LE is significantly 
reduced in the C/EBP!-null mice compared to the wild-type (WT) mice of same genetic 
background (15). The goal of the present study was to determine the precise stage at 
which the cell cycle progression is impaired in the mutant uterine LE. To assess cell cycle 
entry and progression through the G1 phase, we monitored the expression of two cell 
cycle markers, minichromosome maintenance molecule 3 (MCM3) and Ki67, by IHC 
analysis. MCM3 is a major component of the “pre-replicative licensing complex” that is 
highly expressed during G1 phase in preparation for entry into S phase (27).  Ki67 is a 
nuclear antigen that is expressed at all stages of active cell cycle (27, 28). At 8 and 12 h 
after E treatment, which correspond to early and late G1, both MCM3 and Ki67 were 
expressed at comparatively equal levels in WT and C/EBP!-null epithelia (Fig 2.2, A & 
B). This observation suggested that both WT and mutant LE cells are competent to enter 
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G1 from G0 phase upon E stimulation and able to progress through G1 phase of the cell 
cycle. 
 
To examine the G1-S transition and S-phase activity, ovariectomized WT and C/EBP!-
null mice were treated with E for durations of 8, 12, 15 and 18 h. A one-hour pulse of 
BrdU, a thymidine analogue, was administered to these mice immediately prior to 
collection of uterine tissue. Nuclear immunostaining of BrdU, which is indicative of S 
phase activity, was absent in untreated ovariectomized WT and C/EBP!-null mice (data 
not shown). Sporadic staining of BrdU was visible in ~5% WT LE cells at 8 h following 
E treatment (Fig 2.3 A, panel a, and 2.3 B). This staining was significantly increased by 
12 h, indicating the entry of a substantial number (~16%) of uterine LE cells into S-phase 
(Fig 2.3 A, panel c, and Fig. 2.3 B). The BrdU incorporation increased further at 15 h 
(Fig 2.3 A, panel e). By 18 h of E treatment, almost all uterine LE cells are actively 
undergoing DNA replication in WT mice (Fig 2.3 A, panel g). In comparison, in the 
uterine LE of C/EBP!-null mice, BrdU incorporation was drastically reduced at all time 
points tested following E treatment (Fig 2.3 A, panels b, d, f, h; Fig 2.3 B). While greater 
than 90% of WT LE cells showed BrdU-positive staining at 18 h following E treatment, 
only 10% were BrdU positive in the mutant epithelium (Fig 2.3, A & B). These results 
suggested that in the absence of C/EBP!, E-stimulated uterine LE cells are severely 
impaired in their ability to undergo DNA replication.  
 
One would predict that the blockade in S phase activity in C/EBP!-null uterine LE would 
result in a loss of E-induced mitotic activity in these cells. To test this prediction, we 
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employed an antibody that specifically recognizes phosphorylated serine 10 of histone 
H3. This marker typically localizes to distinct regions of chromosome condensation 
during mitosis, appearing as punctuate loci in the nucleus (29). As expected, the levels of 
phospho-histone H3 staining steadily increased from 18 to 20 h and declined modestly 
from 20-24 h, in the E-treated WT uterine LE (Fig 2.4 A). However, in the absence of 
C/EBP!, the phospho-histone H3 staining was absent or drastically reduced in LE when 
compared to WT uteri. (Fig 2.4, A & B). Consistent with the S-phase impairment that we 
had observed, the C/EBP!-null mice displayed virtually no evidence of mitotic activity 
throughout the LE cell layer. The mitotic block was further confirmed by examining the 
mRNA and protein levels of cyclin B, a well-defined regulator of mitosis. As expected, 
the expression of cyclin B2 mRNA (Fig 2.4 C, panel a) and protein (Fig 2.4 C, panel b) 
was greatly reduced in C/EBP!-null LE compared to the WT tissue (Fig 2.4 C).  
 
Altered expression and activities of multiple G1-S phase regulatory factors in 
C/EBP!-null uterine epithelium 
 
The progression of the cell cycle from G1 to S-phase is orchestrated by stage-specific 
cyclins, cyclin-dependent kinases and other cell cycle regulatory factors (28). Cyclin D1 
is typically expressed early in the G1 phase and associates with cdk4 to promote S-phase 
entry. Cyclins E and A then associate with cdk2 and directly regulate the S-phase 
progression. cdk2 achieves full functionality through a Cdk-Activating Kinase (CAK)-
dependant phosphorylation of a threonine residue (Thr160) (30, 31). To analyze the basis 
of the lack of E-induced proliferation in the C/EBP!-null epithelium, we, therefore, 
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examined the expression levels of each of these S-phase-regulatory cyclins and cdks in 
WT and C/EBP!-null LE cells at 15 h following E-treatment.  
 
When the expression of cyclin D1 and cyclin A mRNAs was examined in WT and 
C/EBP!-null uterine LE cells, no significant difference in their levels in WT and mutant 
epithelia was seen (Fig 2.5 A, panels a & c). Immunohistochemistry of uterine sections at 
15 h following E treatment revealed that the levels of the cyclin D1 protein and its 
nuclear localization were unaltered (Fig. 2.5 A, panel b). Interestingly, we noted a modest 
decrease in the levels of cyclin A protein in the nuclei of mutant LE cells (Fig 2.5 A, 
panel d). We did not observe any significant difference in the expression levels of cdk2 
and cdk4 mRNAs in WT and C/EBP!-null uterine epithelial cells at 15 h following E 
treatment (Fig 2.5 A, panel e, data not shown). In contrast, we noted an approximately 
50% reduction in the expression of cyclin E mRNA in the C/EBP!-null uterine epithelial 
cells compared to the WT cells (Fig 2.5 B, upper panel). This decrease in cyclin E levels 
in the mutant epithelium was further confirmed by IHC of tissue sections collected at 15 
h following E-treatment (Fig 2.5 B, lower panels). Most notably, we failed to detect 
nuclear localization of cyclin E in mutant epithelial cells. While the presence of this 
cyclin was prominent in the nuclei of WT epithelial cells (Fig 2.5 B, lower panels a and 
c), its immunostaining was markedly reduced and predominantly cytoplasmic in the 
C/EBP!-null epithelium (Fig 2.5 B, lower panels b and d). Coincident with the reduced 
nuclear presence of cyclin E, we observed that the activation of cdk2 via phosphorylation 
of its Thr160 residue was diminished in C/EBP!-null epithelial cells (Fig 2.5 A, panel f). 
The reduced expression of cyclin E, combined with a lack of its nuclear localization in 
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the epithelial cells, therefore, contributes to impaired activation of cdk2, leading to the 
defect in E-induced S-phase activity in the C/EBP!-null uterine LE. 
 
The E2Fs 1, 2 and 3 belong to a family of six known E2Fs, and have been implicated in 
several studies as being the most important regulators of the G1-S checkpoint (32). Upon 
mitogenic stimulation, activated E2F factors transactivate downstream genes, including 
cyclin E, promoting progression through the cell cycle into S-phase. The mRNA levels of 
these three E2Fs were investigated in WT and C/EBP!-null LE cells. While the 
expression levels of E2F-1 and E2F-2 displayed no statistically significant difference 
between WT and mutant epithelial cells, the E2F-3 mRNA level was diminished by 
approximately 50% in the LE cells lacking C/EBP! (Fig. 2.6 A, panels a-c). This 
observation was further confirmed by IHC analysis, showing reduced nuclear expression 
of E2F-3 protein in the LE of WT and C/EBP!-null tissue sections following 15 h of E 
treatment (Fig. 2.6 B). This finding is consistent with previous reports that E2F-3 plays 
an essential role in promoting the S-phase activity (33, 34). It is of interest to note that the 
steady state expression level of E2F3 mRNA is considerably higher than that of E2F1 or 
E2F2 mRNA in E-treated uterine LE (Fig. 2.6 A). Therefore, the reduced levels of E2F-3 
may have a strong impact, resulting in diminished expression of cyclin E mRNA and the 
consequent impaired ability of C/EBP!-null uterine epithelial cells to progress through 
the S-phase of the cell cycle.  
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C/EBP!  is recruited to the E2F3 promoter in response to E 
 
C/EBP! manifests its gene regulatory role by binding to the promoters of its target genes. 
To explore the possibility that C/EBP! directly mediates the E-induced expression of 
E2F-3 and/or cyclin E, we examined the promoter regions of these genes by in silico 
analysis. We identified four putative binding sites for C/EBP!! in the E2F3 promoter and 
two such sites in the cyclin E promoter as indicated in the Materials and Methods. We 
then performed ChIP analysis to test for C/EBP! occupancy at these sites. While we did 
not detect C/EBP! recruitment to any of the putative binding sites in the cyclin E 
promoter sites (data not shown), we found a robust recruitment of this transcription factor 
to the –584 region of the E2F3 promoter following E treatment (Fig 2.6 C).  
 
Alterations in the G1-S inhibitory factors p27 and p21 in C/EBP!-null uterine 
epithelium 
 
The cyclin-dependant kinase inhibitors (CKIs) block the cell cycle progression by 
negatively regulating the actions of cyclin-cdk complexes (28, 35). The predominant 
CKIs belong to the INK4 and Cip/Kip family of inhibitors, the latter of which includes 
p21 and p27, two well characterized G1-S regulators (35). Both p21 and p27 directly 
inhibit the cyclin E/cdk2 and cyclin A/cdk2 complexes, thereby controlling the S-phase 
activity. We found that the levels of p27 mRNA were only modestly elevated in C/EBP!-
null LE cells compared to WT cells at 0, 12 and 15 h after E treatment (Fig 2.7 A). 
Strikingly, however, prominent nuclear localization of the p27 protein was observed in 
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the C/EBP!-null epithelium at 15 and 18 h of E-treatment (Fig 2.7 B, panels b and d). 
This nuclear accumulation of p27 protein coincided with the block in S-phase progression 
and lack of G2-M transition of these cells. Phosphorylation of p27 at threonine 187 by 
cdk2 serves as a signal for the ubiquitin-mediated degradation of this inhibitor (36). 
Consistent with the lack of cdk2 activity in the C/EBP!-null LE cells, we observed that 
phosphorylation of p27 at Thr187 was reduced in these cells compared to WT cells, as 
indicated by IHC and western blotting (Fig 2.7 C & Fig 2.7 D).  
 
We also detected an increased level of p21 mRNA in C/EBP!-null LE cells relative to 
WT cells at all times following E treatment (Fig. 2.7 E). Of particular note was the 
greater than two-fold higher expression of p21 mRNA (Fig. 2.7 E) and a marked 
enhancement in p21 protein level in the mutant epithelium compared to the WT tissue at 
18 h after E treatment (Fig. 2.7 F). It is likely that this increased expression of p21 in 
C/EBP!-null epithelial cells contributes to the maintenance of the G1-S arrest. 
 
Activation of DNA damage checkpoint machinery and expression of repair proteins 
in the C/EBP!-null uterine epithelium following the G1-S arrest 
 
To further investigate the gene networks underlying C/EBP! function during E-induced 
proliferation of the uterine LE, we compared the gene expression profiles of WT and 
C/EBP!-null uterine LE cells. Briefly, ovariectomized mice were treated with E, and 
after 18 h, the LE cell layer was isolated and total RNA was subjected to DNA 
microarray analysis using Affymetrix murine arrays as described in the Materials and 
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Methods. The results indicated that the expression of 620 genes was upregulated and that 
of 116 genes was downregulated greater than 2-fold in C/EBP!-null uterine LE cells 
compared to WT cells (C. R. Ramathal and M. K. Bagchi, unpublished results). Using 
gene ontology analysis, we identified a subset of genes with well-established roles in 
DNA damage response among those markedly up regulated in the LE lacking C/EBP!. 
These genes encoded factors regulating cell cycle checkpoints (such as Atm, Atr, Birk5, 
Skp2, Cdc20), DNA repair (such as Rad18, Rad51, Rad54B, Rpa1, Mre11A, Exo1, Xrcc5) 
and apoptosis (such as Casp3, Cdh2, Tp73l). A summary of genes regulated by C/EBP! 
in E-treated uterine epithelial cells is provided in Appendix A. 
 
A potential consequence of compromised DNA replication is collapse of replication forks 
or creation of aberrant structures at the replication forks, making the DNA prone to 
damage, such as single-strand or double-stand break formation (37, 38). These DNA 
lesions are detected by ATM and ATR proteins, which are primary sensors and 
transducers of the DNA damage response (37, 38). These proteins signal downstream to 
the checkpoint kinases, Chk1 and Chk2, and the tumor suppressor p53 in an attempt to 
correct the defect and remove damaged cells by triggering apoptosis (Fig. 2.8 A). An 
additional mechanism involves the recruitment of the E3 ubiquitin ligase Rad18 to stalled 
replication forks. Rad18, in partnership with Rad6, is thought to assist in disassembly of 
the aberrant fork (39). Consistent with the results of our microarray analysis, real-time 
PCR confirmed the up-regulation of mRNAs corresponding to Atm and Atr in the 
C/EBP!-null uterine LE (Fig. 2.8 B). Activation of the ATM and ATR kinases via unique 
phosphorylation events signals to the cell cycle checkpoint molecules that govern the G1-
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S transition (37, 38). As shown in Fig. 8C, in the E-treated WT uterine LE, ATM exists in 
an inactive non-phosphorylated form, indicating the absence of any DNA damage 
response. In contrast, prominent nuclear staining for the active phosphorylated (Ser1981) 
form of ATM was detectable throughout the C/EBP!-null uterine LE at 18 h following E-
treatment (Fig. 2.8 C). In addition, accumulation of phosphorylated (Ser139) histone 
H2AX, a well-established marker of ATM-dependent DNA damage response (40, 41), 
was observed at 18-20 h in C/EBP!-null uterine epithelial cells (Fig 2.8 E, panels a & b). 
As further evidence of replication fork lesions, we observed an increased nuclear 
expression of Rad18 in C/EBP!-null epithelial cells compared to WT cells (Fig 2.8 E, 
panels c & d).  
 
We next assessed the occurrence of a DNA damage response downstream of ATM/ATR 
activation by monitoring other markers, such as checkpoint kinase 1 (Chk1), and p53 in 
the C/EBP!-null epithelium. Phosphorylation of Chk1 at Ser296 by ATM indicates that 
the DNA damage response and checkpoint activation are initiated (37). Phosphorylation 
of p53 at the Ser-15 residue by the activated ATM-Chk1 pathway causes p53 
transcriptional activation (37). Western blotting experiments were performed, using 
soluble lysates prepared from LE cells obtained from uteri collected from WT and 
C/EBP!-null mice following E treatment for 18 h. The data revealed a marked elevation 
in the levels of phosphorylated forms of Chk1 (Ser296) and p53 (Ser15) (Fig 2.8 D). 
There was also a significant increase in the level of total p53 protein in the C/EBP!-null 
LE cells relative to WT cells at 18 h of E treatment (Fig. 2.8 E). It was previously 
reported that a consequence of up regulation and activation of p53 is elevated expression 
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of its transcriptional target p21 (37, 42). We indeed saw a significant rise in the level of 
p21 protein (Fig. 2.7 E), which presumably helps maintain the cell-cycle arrest in the 
mutant epithelium. Collectively, our results established that the lack of C/EBP!, which 
leads to a block in E-mediated proliferation of the uterine epithelium, triggers the 
ATM/ATR-dependent DNA damage response pathway, and activates p53-mediated 
signaling that helps maintain the cell cycle block. 
 
Increased apoptosis in the C/EBP!-null uterine epithelium following the G1-S 
arrest 
 
Phosphorylation of p53 at Ser15 by ATM-Chk1/Chk2 pathway promotes its stabilization 
by preventing ubiquitination and degradation (37, 43). P53 is known to promote the 
expression of several pro-apoptotic genes, which in turn stimulate the mitochondrial 
pathways leading to caspase activation (41). We, therefore, investigated the possibility 
that the activation of an ATM/ATR/Chk1/Chk2 DNA damage response mechanism in 
C/EBP!-null uterine LE cells, which results in activation and accumulation of p53, 
commits these cells to enter programmed cell death. In order to assess the initiation of 
apoptosis in E-treated uterine LE cells of WT and C/EBP!-null mice, we first examined 
the activation of caspase 3 (Casp3), a well-known marker of this process (41, 44). We 
performed IHC analysis to determine the levels of Casp3 and its proteolytically cleaved 
active form (cl-Casp3) in these cells. Examination of the levels of full-length Casp3 at 48 
h following E-treatment detected a higher expression of this protein in the cytosolic 
compartment of C/EBP!-epithelial cells compared to the WT epithelial cells (data not 
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shown). When we assayed for the presence of cl-Casp3 at the 48 h time point, an 
increased presence of this apoptosis marker was evident in the C/EBP!-null epithelium 
(Fig 2.9 A).  
 
We next performed TdT-mediated dUTP nick-end-labeling (TUNEL) staining to assess 
the extent of DNA degradation in apoptotic cells of the uterine epithelia of WT and 
C/EBP!-null mice. We detected a notable increase in TUNEL staining at discrete foci in 
the LE of mutant mice compared to WT mice at 48 h of E-treatment (Fig 2.9, B & C). 
These data suggested that the arrest of the E-stimulated C/EBP!-null LE cells at the S 
phase of the cell cycle triggers the activation of p53-dependent mechanisms that increase 
their susceptibility to programmed cell death and affect their survival.  
 
 
2.5. DISCUSSION 
 
C/EBP!  is an essential mediator of E-induced S-phase entry of the uterine epithelial 
cells.  
 
Our previous studies revealed that C/EBP! is a major downstream target of E regulation 
in the uterus (15). The discovery that the uterine epithelium in C/EBP!-null mice is non-
receptive to embryo implantation (15) prompted us to utilize this animal model to 
investigate the functional role of C/EBP! and its downstream pathways in uterine 
epithelial biology. The studies presented here demonstrated that the absence of C/EBP! 
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results in a significant defect in the ability of uterine LE cells to proliferate in response to 
E stimulation. This is evidenced by a major impairment in DNA replication activity and 
multiple dysregulated cell cycle components in the C/EBP!-null uterine LE. We 
determined that C/EBP!-null uterine LE cells are able to enter the cell cycle and progress 
through the G1 phase before getting arrested in the S-phase (Fig. 2.2 & 2.3). Ablation of 
the C/EBP! gene, therefore, led to a complete loss of E-induced DNA replication and 
subsequent mitotic activity in the uterine LE. We, therefore, uncovered a role for C/EBP! 
as an essential mediator of E-induced DNA replication in the uterine epithelium. 
Interestingly, we uncovered in separate studies that C/EBP!-null uterine stromal cells 
progress normally through S-phase but encounter a block in mitosis (Wang, W. et al., In 
press). This observation suggests that C/EBP! may regulate the two critical cell cycle 
checkpoints in independent mechanisms based on its cellular context.     
 
Previous reports documented that E administered to ovariectomized mice promotes the 
G1 to S phase transition of the uterine LE cells (1, 4, 26). Studies by Pollard and 
coworkers indicated that E-induced nuclear localization of cyclin D1 is an essential event 
that permits S-phase entry of the uterine LE cells (1, 26).  It was shown that in the 
presence of E, the activation and nuclear translocation of cyclin D1 occurs via the 
inhibition of GSK-3! activity (25). It was further proposed that P opposes the 
proliferative actions of E by allowing phosphorylation of cyclin D1 by GSK-3! and 
subsequent nuclear export of this cyclin. In the present study, we noted that the nuclear 
presence of cyclin D1 remained unaltered in the S-phase-arrested LE cells of C/EBP!-
null uteri (Fig 2.5 B). These results suggested that C/EBP! regulation of uterine LE cell 
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proliferation occurs via a mechanism that is unrelated to the nuclear translocation of 
cyclin D1. Our findings are corroborated by previous reports that the nuclear entry of 
cyclin D1 occurs in the absence of C/EBP! in the liver and mammary epithelium (16, 
45).  
 
A major finding of our study is that, upon E treatment, the level of cyclin E mRNA is 
notably less in the C/EBP!-null LE cells compared to the WT LE cells and the cyclin E 
protein failed to localize to the nucleus (Fig. 2.5 B). It is likely that the C/EBP!-mediated 
entry of LE cells into the S phase of the cell cycle primarily involves regulation of cyclin 
E-cdk2 function. During the S phase of the cell cycle, the active cyclin E/cdk2 complex is 
localized in the nucleus of WT LE cells and coordinates the assembly of DNA replication 
factors onto the origins of replication (28, 47). In contrast, in C/EBP!-null uteri, a 
combination of reduced expression of cyclin E and its absence from the nucleus of LE 
cells would prevent its partnership with cdk2 and its S-phase promoting activities. 
Consequently, inadequate cdk2 activation in C/EBP!-null LE cells would also contribute 
to an S-phase blockade (Fig 2.5 B). Tong and Pollard previously reported that P abolishes 
E-induced cyclin E-cdk2 activity in the uterine epithelium (26). This report is consistent 
with our observation that simultaneous administration of P suppresses E-induced C/EBP! 
expression, which in turn controls the expression and nuclear presence of cyclin E. Our 
finding is also consistent with a previously published microarray study conducted using 
whole uteri of mice (2). In that study, the acute administration of E stimulated the 
expression of uterine cyclin E and cdk2, although the cell-type(s) in which these 
molecules are expressed remained unclear. 
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Previous reports indicated that the loss of C/EBP! results in reduced cyclin E expression, 
reduced cdk2 functionality and a decreased proliferative activity in mammary epithelia 
and in hepatocytes during liver regeneration (16, 45). The precise mechanism by which 
C/EBP! regulates the expression and nuclear localization of cyclin E is presently 
unknown. Several studies have proposed that cyclin E is a target of transcriptional and 
post-translational regulation by the E2F transcription factors, which are important 
regulators of the G1-S transition and DNA replication (32-34, 48-50). Interestingly, 
among the E2F family members that we have examined, E2F3 is the most highly 
expressed in the WT LE cells (Fig. 2.6 A, panel d). It displayed reduced expression levels 
in the C/EBP!-null uterine epithelium (Fig 2.6 A, panel c), while the levels of E2F1 and 
E2F2 remained unaltered. ChIP analysis demonstrated the recruitment of C/EBP! to the 
proximal promoter region of E2F3, strongly suggesting that E2F3 is a primary target of 
C/EBP! in uterine LE cells. We postulate that E2F3 regulates cyclin E expression, which 
in turn controls the entry of uterine LE cells into the S phase of the cell cycle.  
 
We found that the CDK inhibitors, p21 and p27, also play important roles in blocking E-
induced cell cycle progression in C/EBP!-null uterine LE. In G0 and early G1 phases, a 
high level of p27 is present in hormone-withdrawn uterine LE. P27 binds to the cyclin E-
cdk2 complex and inhibits its activity. Upon E-stimulation, p27 protein levels decline via 
ubiquitin-mediated degradation. In late G1, p27 becomes a substrate of phosphorylation 
by the cyclin E-cdk2 complex. Phosphorylated p27 is released from the cyclin E-cdk2 
complex, exits its nuclear location and undergoes degradation, resulting in cyclin E-cdk2 
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activation (28, 36, 46, 51). Consistent with this scenario, we observed that the E-
stimulated WT uterine LE cells efficiently targeted p27 for ubiquitin-mediated 
degradation by phosphorylation thereby depleting nuclear p27 protein upon S phase entry 
(Fig 2.7 C & 2.7 D). In contrast, a robust nuclear accumulation of p27 was detected in 
C/EBP!-null epithelia, coincident with the drastically reduced cyclin E levels in the 
nuclear compartment and the cell-cycle blockade in S-phase (Fig 2.7 B). Our results 
supported the view that the accumulation of p27 protein arises from inefficient 
phosphorylation of p27 by the cdk2/cyclin E complex and consequent lack of ubiquitin-
mediated degradation of p27 in the mutant LE cells (Fig 2.7 C & 2.7 D). The nuclear 
retention of p27 suggests that it may interact with and inactivate any residual cyclin E-
cdk2 or cyclin A-cdk2 complex that might form in the nuclei. We also noted a 
remarkable rise in the level of the p21 inhibitor at later stages of the cell cycle arrest. The 
sustained presence of p27 and p21 inhibitors during early and late S-phase maintains the 
blockade of cyclin/cdk2 activities, preventing uterine LE cells from completing DNA 
replication and entering mitosis. 
 
E stimulation in the absence of C/EBP!  activates the DNA damage checkpoint 
pathway in the uterine epithelium 
 
Dysregulation of cyclin E was previously reported to cause destabilization of pre-
replication complexes necessary for DNA synthesis (47). We postulate that a defect in 
cyclin E/cdk2-controlled replication fork assembly is encountered when E-stimulated 
C/EBP!-null LE cells traverse through G1 and attempt to progress through S-phase. We 
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favor the hypothesis that the onset of a replication defect in E-stimulated C/EBP!-null 
uterine LE triggers the DNA damage checkpoint activation. In mammalian cells, stalled 
replication forks or replication-blocking lesions are typically recognized by the ATM 
/ATR kinase checkpoint pathways as DNA damage signals, triggering a series of well-
defined molecular events, culminating in cell cycle arrest and DNA repair (37, 38, 41, 43, 
52). Stalled replication forks also recruit the ubiquitin ligase Rad18, a key component of 
the replication repair pathway (39, 53). In our studies, the ATM-dependent checkpoint 
pathway is activated in C/EBP!-null uterine LE cells as evidenced by the enhanced 
accumulation of active, phosphorylated forms of ATM kinase and its downstream targets, 
histone variant H2AX, Chk1 and p53 (Fig 2.8). The increased presence of Rad18 in 
nuclei of replication-arrested C/EBP!-null epithelial cells further confirms the replication 
fork lesions in mutant LE cells. Activation of Chk1 via phosphorylation at Ser296 is 
known to affect S-phase progression (43, 51). Furthermore, ATM/ATR-dependent 
phosphorylation of p53 at Ser15 leads to its activation and stabilization. The 
transcriptionally active p53, in turn, promotes the synthesis of p21, which directly 
inhibits the cdk2/cyclin E complex (26, 35, 37, 46). In this manner, activation of p53-
dependent mechanisms downstream of DNA damage response helps maintain the DNA 
replication arrest in hormone-stimulated C/EBP!-null epithelial cells. 
 
Loss of C/EBP!  expression in uterine epithelium triggers apoptosis: implications for 
E-dependent cell survival 
 
In addition to its mitogenic effects, E is also known to promote cell survival by acting as 
an anti-apoptotic agent (54, 55). A block in E-induced uterine LE cell proliferation in the 
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absence of C/EBP! may trigger apoptosis, which is the culmination of a cascade of 
molecular steps including cell cycle withdrawal and DNA fragmentation (44). We also 
considered apoptosis as a potential biological end-point for S-phase-arrested C/EBP!-
null uterine LE cells since there is a strong connection between the ATM/p53-dependent 
checkpoint response and removal of damaged cells via programmed cell death (37, 41). 
One of the essential players in apoptosis is the serine-protease Casp3, which plays a 
central role in coordinating a variety of downstream events leading to cell death (41, 44). 
Our studies revealed that a subpopulation of E-treated C/EBP!-null LE cells blocked in 
S-phase entered the apoptotic pathway as evidenced by the increased presence of the 
cleaved, active form of Casp3 in these cells compared to WT LE cells (Fig 2.9 A). 
Additionally, we noted a significant increase in cell death due to DNA fragmentation in 
C/EBP!-null epithelium compared to the WT tissue (Fig 2.9, B & C). The genetic 
deletion of C/EBP! has been previously linked to increased apoptosis and reduced 
tumorigenesis in skin keratinocytes (56, 57). It is likely that the majority of the C/EBP!-
null uterine LE cells undergo DNA repair and recovery, thereby preventing widespread 
apoptosis in the epithelium. In support of this concept, the expression of several proteins 
associated with the DNA repair pathway such as Rad18, Rad51, Rad54B, Rpa1, Mre11A, 
Exo1, Xrcc5 was elevated in uterine epithelium lacking C/EBP!.  
 
In conclusion, C/EBP! is an early and critical mediator of the E-controlled proliferative 
response in the uterine LE. The functional link between E and C/EBP! provides a novel 
mechanism by which this hormone controls the expression, localization and activity of 
specific cell cycle regulatory molecules, such as E2F3, cyclin E, p27 and p21, to 
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influence DNA synthesis in the LE cells (Fig 2.10). The downstream actions of this key 
transcription factor are also indispensable for DNA repair and cell survival, allowing the 
preparation of a functional uterine epithelium for establishment of pregnancy. 
Furthermore, the role of C/EBP! as a mediator of proliferative as well as anti-apoptotic 
effects of E in the uterine epithelium presents it as a potential target for anti-cancer 
therapeutics in preventing E-dependent endometrial cancers. 
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2.7. FIGURES AND LEGENDS 
FIG. 2.1. 
                           
Figure 2.1. Uterine epithelial cell proliferation and C/EBP!  expression in response 
to E & P 
 
WT mice were ovariectomized and treated with E or E plus P as described in Materials 
and Methods. Uteri were collected from these mice at 2 and 11 h after hormone 
administration.  
 
A. IHC analysis of Ki67 expression in 11 h E- and E+P-treated uterine sections.  
 
B. Primary uterine LE cells were isolated from uteri of WT mice treated with E or E plus 
P. Total RNA was analyzed by real-time PCR using C/EBPb-specific primers. The fold 
changes indicate gene expression levels at different times relative to E-treated cells at 0 
h. Statistically significant differences (P<0.05) are indicated by *.  
 
C. IHC analysis of C/EBPb expression in 2 h E- and E+P-treated uterine sections. 
LE:luminal epithelium, S:stroma. 
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FIG. 2.2. 
        
 
Figure 2.2. The C/EBP!-null uterine epithelial cells enter into G1 phase in 
response to E 
 
WT or C/EBPb (-/-) mice were ovariectomized and treated with E for 8 or 12 h.  
LE: epithelium, S:stroma.  
 
A. IHC analysis of MCM3 expression in 8 h and 12 h E-treated WT and C/EBP!-null 
uteri. Bar, 20 mm.  
 
B. IHC analysis of Ki67 expression in 12 h E-treated WT and C/EBP!-null uteri.  
 
Staining for MCM3 or Ki67 is indicated in red and DAPI-stained nuclei are shown in blue. 
Bar, 50 mm. 
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FIG. 2.3. 
  
   B 
              
 
Figure 2.3. E-induced S-phase activity is impaired in C/EBP!-null uterine 
epithelium 
 
WT or C/EBPb (-/-) mice were ovariectomized and treated with E. Uteri were collected at 
8, 12, 15 and 18 h following E administration. Mice were injected with BrdU 1 h prior to 
sacrifice.  
A. IHC of uterine sections using an anti-BrdU antibody. Bar, 50 mm. Red deposits 
indicate positive staining for BrdU.  
 
B. For quantitation of BrdU incorporation, positively stained nuclei of LE cells were 
counted as described in the Materials and Methods. Statistically significant differences 
(P<0.05) are indicated by *. 
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FIG. 2.4. 
                  
 
Figure 2.4. Mitotic activity is absent in E-treated C/EBP!-null uterine epithelium 
 
WT or C/EBPb (-/-) mice were ovariectomized and treated with E. Uteri were collected at 
18, 19, 20, 22 and 24 h following E administration, and sections were subjected to IHC.  
 
A. Analysis of mitotic activity in the uterine LE using an anti-phospho-histone H3 (Ser10) 
antibody. Specific staining is indicated in red and DAPI-stained nuclei are shown in blue. 
Bar, 50mm.  
 
B. Quantitation of nuclei stained positively for phospho-histone H3.   
 
C. Expression of cyclin B2 mRNA and protein in the uterine LE upon E treatment. (panel 
a) Primary uterine LE cells were isolated from uteri obtained from mice following 19 h of 
E-treatment. Total RNA was prepared and the expression level of cyclin B2 mRNA was 
determined by real-time PCR. The fold changes indicate cyclin B2 mRNA expression 
level relative to E-treated WT cells at 0 h.  (panel b) Uterine sections of mice treated with 
E for 19 h were subjected to IHC using an anti-cyclin B2 antibody. Positive staining for 
cyclin B2 is indicated in red and DAPI-stained nuclei are shown in green. Bar, 50 mm. 
Statistically significant differences (P<0.05) are indicated by *. 
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FIG. 2.5. 
 
           
Figure 2.5. Expression and localization of G1-S cyclins and cdks in E-treated 
C/EBP!-null uterine epithelium 
 
A. LE cells were isolated from uteri of ovariectomized WT or C/EBPb (-/-) mice treated 
with E for 0 and 15 h. Expression levels of cyclin D1 (panel a), cyclin A (panel c) and 
cdk2 (panel e) mRNAs were determined by real-time PCR. NS indicates differences that 
are not statistically significant (P>0.05). Sections of uteri collected at 15 h following E 
treatment were subjected to IHC using antibodies against cyclin D1 (panel b) and cyclin 
A (panel d). Positive staining is indicated in red and DAPI-stained nuclei are shown in 
blue. (panel f) Lysates of LE cells were prepared at 0 and 15 h of E treatment and 
analyzed by western blotting using antibodies against cdk2 and phosphorylated cdk2 
(Thr160).  
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Figure 2.5. continued. 
                  
 
 
B. LE cells were isolated from uteri of mice treated with E for 0, 12 and 15 h. Expression 
of cyclin E mRNA (upper panel) was determined by real-time PCR. The fold changes 
indicate cyclin E mRNA expression level relative to E-treated WT cells at 0 h. 
Statistically significant differences (P<0.05) are indicated by *. Lower panels: Sections of 
uteri obtained from mice treated with E for 15 h were subjected to IHC using anti-cyclin E 
antibody. Panels c and d are displayed at a magnification of 100mm. White arrows 
indicate nuclear staining for cyclin E, while yellow arrowheads indicate cytosolic 
localization. Positive staining for cyclin E is indicated in red and DAPI-stained nuclei are 
shown in blue. LE:luminal epithelium, S:stroma.  
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FIG. 2.6. 
 
Figure 2.6. C/EBP!  regulates expression of the E2F family genes in the E-treated 
uterine epithelium. 
 
A. LE cells were isolated from uteri of ovariectomized WT or C/EBPb (-/-) mice following 
treatment with E for 0, 12 and 15 h. Expression levels of E2F-1 (panel a), E2F-2 (panel 
b) and E2F-3 (panel c) were determined by real-time PCR. The fold changes indicate 
mRNA expression levels of the E2F genes relative to E-treated WT cells at 0 h. Panel d: 
Relative steady state levels of mRNAs for E2Fs 1, 2, and 3 in primary LE cells, obtained 
from uteri treated with E 15 h, are shown following normalization with 36B4 mRNA level. 
Statistically significant differences (P<0.05) are indicated by *.  
 
B. Uteri from WT and C/EBPb-null mice treated with E for 15 h were collected and 
sections were subjected to IHC using anti-E2F-3 antibody. Positive staining for E2F-3 is 
indicated in red and DAPI-stained nuclei are shown in blue.  
 
C. ChIP analysis: LE cells were isolated from uteri of ovariectomized WT mice following 
treatment with E for 12 h. ChIP was performed as described in Materials & Methods 
using antibodies against C/EBPb, RNAP polymerase II (RNAP II) and rabbit IgG. 
Relative levels of recruitment at various sites on the E2F3 promoter were determined by 
real-time PCR and normalized to input DNA and RNAP II values.  
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FIG. 2.7. 
 
 
Figure 2.7. Expression of the cdk inhibitors p27 and p21 in the C/EBPb-null uterine 
epithelium in response to E 
 
A. LE cells were isolated from uteri of ovariectomized WT or C/EBPb (-/-) mice following 
treatment with E for 0, 12, 15 and 18 h. Expression levels of p27 mRNA were 
determined by real-time PCR. The fold changes indicate expression levels of p27 and 
p21 mRNA relative to E-treated WT cells at 0 h. Statistically significant differences 
(P<0.05) are indicated by * and non-significant differences are indicated by N.S. 
 
 
 
 
 62 
Figure 2.7. continued. 
 
B. Uterine sections of WT and C/EBPb-null mice treated with E for 15 h (B, panels a & b) 
and 18 h (B, panels c & d) were subjected to IHC using an anti-p27 antibody Positive 
staining for p27 is indicated in red and DAPI-stained nuclei are shown in blue. Nuclear 
presence of p27 is indicated by white arrowheads in panels b and d. Bar, 50 m.  
 
C. IHC analysis of phosphorylated p27 (Thr 187). Positive staining for phospho-p27 is 
indicated by red deposits.  
 
D. Lysates of LE cells isolated from uteri of mice treated with E for 15 h were analyzed 
by western blotting using the anti-phospho p27 (Thr187) antibody. Immunostaining of 
calnexin served as a loading control.  
 
E. Expression levels of p21 mRNA were determined by real-time PCR.  
 
F. LE cells were isolated from uteri of mice treated with E for 0 and 18 h. Cell lysates 
were analyzed by western blotting using anti-p21 antibodies.  
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FIG. 2.8. 
 
   
Activation of the DNA damage checkpoint pathway in E-treated C/EBPb-null 
uterine epithelium 
 
A. A schematic of the major DNA damage checkpoint pathways leading to p53-
dependent apoptosis or p21-mediated cell cycle arrest.  
 
B. LE cells were isolated from uteri of WT or C/EBPb (-/-) mice treated with E for 0 and 
18 h. Expression levels of ATM (a) and ATR (b) mRNAs were determined by real-time 
PCR. Statistically significant differences (P<0.05) are indicated by *. 
 
C. Uterine sections of WT and C/EBPb-null mice treated with E for 0 and 18 h were 
subjected to IHC using an antibody specific for phosphorylated Ser 1981 of ATM. 
Positive staining for phospho-ATM is indicated in red and DAPI-stained nuclei are shown 
in blue. LE:luminal epithelium, S:stroma. Bar, 50 mm. 
 
D. Lysates of LE cells, isolated from uteri of mice treated with E for 0 and 18 h, were 
analyzed by western blotting using antibodies specific for Chk1, phosphorylated Chk1 
(Ser296), p53, phosphorylated p53 (Ser15), and p21. Immunostaining of calnexin 
indicated equal loading in the lanes (data not shown). 
 
E. Sections of uteri collected from WT and C/EBPb-null mice treated with E for 20 h 
were subjected to IHC using antibodies specific for phosphorylated histone H2A, variant 
X (g-H2AX, panels a & b) and Rad18 (panels c & d). Positive staining is indicated in red 
and DAPI-stained nuclei are shown in green. Bar, 20 µm.  
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FIG. 2.9. 
   
Evidence for increased apoptosis in E-treated C/EBPb-null uterine epithelium  
 
A. Uteri were collected from ovariectomized WT and C/EBPb-null mice treated with E for 
48 h. Uterine sections were subjected to IHC using an antibody specific for the cleaved 
form of caspase 3. Positive staining for cleaved-caspase 3 is indicated in red and DAPI-
stained nuclei are shown in blue. Arrowheads indicate cells that stained positive for 
cleaved-caspase 3 in the uterine LE.  
 
B. Uteri collected from WT and C/EBPb-null mice treated with E for 48 h were sectioned 
and subjected to a TdT-mediated dUTP nick-end-labeling (TUNEL) assay. Positive 
staining for apoptotic cells is indicated in green and DAPI-stained nuclei are shown in 
blue. Arrows indicate apoptotic cells in the uterine LE. 
 
C. Quantitation of epithelial nuclei stained positively in TUNEL assay was performed. 
The data were plotted as percentage of total epithelial cells present in the fields. 
Statistically significant differences (P<0.05) are indicated by *. 
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FIG. 2.10 
 
 
               
 
 
Molecular pathways regulated by C/EBPb during E-induced proliferation of uterine 
epithelial cells 
 
In mouse uterine epithelium, expression of C/EBPb is stimulated by E and opposed by 
simultaneous treatment with P. C/EBPb controls entry of E-stimulated epithelial cells into 
the S phase of the cell cycle by up regulating the expression of E2F3 and cyclin E. It 
also promotes the nuclear localization of cyclin E, which enables the formation of an 
active cyclin E-cdk2 complex critical for DNA replication. Lack of C/EBPb allows nuclear 
accumulation of p27, which contributes to cell-cycle arrest. In the E-stimulated C/EBPb-
null uterine epithelium, stalled DNA replication activates a DNA damage response 
pathway involving ATM/ATR, Chk1/Chk2, Rad18 and p53. The activated p53 maintains 
the block in DNA replication by enhancing the synthesis of the cell cycle inhibitor p21 
and also promotes the removal of damaged cells via caspase-dependent apoptosis. 
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 CHAPTER 3 
 
 
C/EBP!  REGULATES THE SYNTHESIS OF A UNIQUE BASAL LAMINA-LIKE 
EXTRACELLULAR MATRIX THAT PLAYS A CRITICAL ROLE DURING 
IMPLANTATION 
 
 
 
3.1. ABSTRACT 
 
During implantation, the uterine stroma undergoes a remodeling process known as 
decidualization. In vitro, stromal fibroblasts differentiate into large, polyploid cells that 
secrete vast amounts of extracellular matrix proteins such as laminins, collagen IV and 
entactin. Laminins, in particular, are instrumental in the formation of a unique, peri-
cellular basement membrane around decidualized cells. We recently uncovered an 
essential role for the transcription factor C/EBP! in decidualization. Gene expression 
profiling of stromal cells revealed that ECM genes such as laminins "1 and #1, and 
collagen type IV alpha 2 were regulated by C/EBP! during decidualization. The present 
study shows that C/EBP! transcriptionally regulates the synthesis of laminin "1 by 
decidual cells. Additionally, siRNA-mediated silencing of laminin "1 expression rendered 
stromal cells incapable of forming a peri-cellular basement membrane and consequently, 
unable to undergo differentiation. Co-immunoprecipitation studies revealed that laminin 
"1 putatively interacts with the integrin !1 receptor on decidual cells. Interruption of 
laminin "1-integrin !1 interactions by echistatin or silencing of integrin !1 inhibited 
stromal differentiation and activation of FAK, a regulator of actin remodeling. To 
understand the role of laminin "1 in modulating maternal-fetal dialogue, pre-implantation 
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uterine stromal cells were co-cultured with blastocysts. We found that blockade of 
C/EBP! function prevented embryo outgrowth and invasion in these co-cultures. SiRNA-
mediated silencing of laminin "1 expression was also characterized by loss of an invasive 
phenotype in trophoblasts. C/EBP!, therefore, regulates laminin "1-dependent basement 
membrane assembly, a structure essential for proper decidualization of stromal cells and 
pivotal in modulating embryo invasion.        
 
 
3.2. INTRODUCTION 
 
The process of embryo implantation into the endometrium involves a series of complex 
and reciprocal interactions between maternal and fetal tissues. The steroid hormones E 
and P play a pivotal role in coordinating the events surrounding implantation, by 
controlling endometrial proliferation and differentiation in a dynamic manner (1). The 
endometrial stromal differentiation, a process known as decidualization, is triggered by 
embryo implantation and is unique to the mammalian species (2-4). Terminally 
differentiated stromal cells undergo remodeling to form a transient, highly specialized 
tissue mass that completely surrounds the invading embryo and modulates the survival 
and growth of the fetus. It is hypothesized that the decidual cells synthesize a diverse set 
of proteins and hormones that signal to the fetus in a paracrine or juxtacrine manner (5-
7). During the uterine remodeling process, a variety of extracellular matrix (ECM) 
proteins are deposited in a pericellular pattern in the decidual tissue (8-10). Prominent 
among these molecules are laminins, collagen type IV and desmin, which are components 
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of a prototypical basement membrane or basal lamina and are not found outside this 
structure. The present study aims to address the regulation and function of this unique 
basement membrane during decidualization.  
 
The basement membrane is an intricate and dynamic structure that controls 
cellular functions by regulating the interactions between cells and their surroundings and 
modulating external stimuli such as growth factors and cytokines (11). Laminins, a large 
family of glyoproteins, are vital to the biological functions of the basal lamina in many 
different mammalian tissues and organs. The integrity of this multi-molecular structure 
depends on the self-polymerization of laminin subunits and the subsequent interactions 
between the laminins and other ECM molecules (11-14). The assembly of laminins and 
collagen IV forms a polymeric and insoluble structure, which then recruits other ECM 
proteins such as nidogen, fibronectin and entactin. Multiple distinct isoforms exist for 
laminin !, ", and # subunits. Latest reports indicate that at least fifteen different laminin 
heterotrimers can be assembled from five !, three " and three # isoforms (11, 13, 15).  Of 
the laminin subunits, laminin #1 is especially important because it is found in 10 out of 
the 15 laminin trimers. Inactivating mutations in the Lamc1 gene caused early lethality in 
developing embryos (16). Laminins, collagen type IV, and fibronectin are abundant in 
pregnant uteri (9, 10). They are also synthesized by endometrial stromal cells cultured in 
vitro (17, 18). It was speculated that the uterine basement membrane serves as a platform 
for uterine remodeling and embryo invasion during implantation. However, the precise 
function of this unique basement membrane in endometrial stromal differentiation and 
implantation still eludes us.  
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Our lab has recently identified the steroid hormone-regulated transcription factor 
CCAAT Enhancer Binding Protein Beta (C/EBP!) as a critical regulator of endometrial 
function (19-21). We observed that female mice lacking C/EBP! are infertile due to an 
impaired decidual response. A closer examination revealed that C/EBP!-null uterine 
stromal cells are unable to undergo proper proliferation and differentiation (19). This 
observation prompted the examination of gene networks that are regulated by this 
transcription factor in the uterine stromal compartment. Using a DNA microarray 
approach, we were able to identify putative targets of C/EBP! in uterine stromal cells 
isolated from WT and C/EBP!-null mice. We uncovered several categories of genes from 
this analysis. Prominent among these genes were those encoding ECM-related molecules 
involved in basement membrane formation, namely, laminin subunits "1 and #1, collagen 
type IV "2 subunit, and fibulins 1 and 2 (Wang, W. et. al, unpublished). These findings 
raised the possibility that the C/EBP!-regulated ECM molecules participate in the 
formation of a unique basement membrane that supports decidualization and implantation 
in the mouse. We further postulated that the stromal basement membrane critically 
controls the dialogue between maternal decidual cells and the invading embryo during 
implantation. Indeed, the current literature is suggestive of a major role of ECM 
molecules in the basal lamina in modulating embryo growth and survival, underlining the 
need for further investigation (5, 22, 23). The availability of a powerful in vitro primary 
culture system in which uterine stromal cells undergo differentiation into decidual cells 
allowed us to address the above hypotheses (24). In this in vitro system, the stromal cells 
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express high amounts of basal lamina ECM components, making it a suitable 
experimental model for our studies.  
We discovered that C/EBP! regulates the expression of two key laminin subunits, 
laminin "1 and laminin #1, which participate in the formation of a pericellular basal 
lamina-like ECM. Our study provided evidence for a novel role for this ECM in 
endometrial stromal differentiation and cytoskeletal remodeling. Furthermore, we found 
that the basal lamina containing laminin "1 signals via an integrin !1 complex in the 
decidual cell membrane to control differentiation. Additionally, we designed a functional 
in vitro culture system in which pre-implantation blastocysts spread into differentiating 
uterine stromal cells. Using this system, we demonstrated that C/EBP!-directed 
formation of uterine stromal basal lamina-like ECM is critical for embryo invasion.  
 
 
3.3. MATERIALS AND METHODS 
 
Materials 
 
Recombinant mouse laminin-1 was purchased from Trevigen ® (Gaithersburg, MD). The 
integrin inhibitor, Echistatin, "1 variant, was purchased from Sigma Aldrich (St. Louis, 
MO). Laminin- and Matrigel™-coated plates (BD-BioCoat™) Cellware were purchased 
from BD Biosciences (Bedford, MA).  
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Animals, treatments and tissue collection. 
 
All experiments involving animals were conducted in accordance with the National 
Institutes of Health standards for the use and care of animals. The animal protocols were 
approved by the University of Illinois Institutional Animal Care and Use Committee. 
Female mice (CD-1) were sacrified on day 4 of gestation and uteri collected for isolation 
of primary stromal cells (PSC). Artificial decidualization (ADR) was induced in WT and 
C/EBP!-null mice as previously described (25). Mice subjected to ADR protocol were 
killed after 48 h and uteri collected for isolation of PSCs.  
 
Isolation of mouse primary uterine stromal cells and in vitro decidualization. 
 
Isolation of primary uterine stromal cells (PSC) was carried out as described previously 
(24). Briefly, uterine horns of day 4 pregnant uteri were dissected longitudinally to 
expose the lumen and cut into 3-5 mm pieces. Uterine tissue pieces were washed in 
Hanks Balanced Salt Solution (HBSS) and subsequently incubated in HBSS containing 6 
g/L dispase (Invitrogen) and 25 g/L pancreatin (Sigma) for 1 h at RT followed by 10 min 
at 37°C. Uterine pieces were gently mixed to release uterine epithelial clumps into the 
supernantant and the supernantant discarded. The partially digested uterine tissue pieces 
were washed in HBSS and incubated in HBSS containing 0.5 g/L collagenase (Sigma) for 
45 min at 37°C.  After incubation, tissue pieces were vortexed to release stromal cell 
clumps into the supernantant. The turbid supernatant containing stromal cells was filtered 
through a 70 µm cell sieve (BD) to separate digested uterine tissue pieces from cells.  
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Filtered cells were resuspended in Dulbecco’s modified Eagle’s Medium-F12 medium 
(DMEM-F12A; with 100 unit/liter penicillin, 0.1 g/liter streptomycin, 1.25 mg/liter 
fungizone) containing 2% heat-inactivated fetal bovine serum and live cells were 
assessed by trypan blue staining using a hemocytometer. Cells (2.5x105) were seeded in 
6-well cell culture plates. Alternatively, approximately 4x104 cells were seeded in 2- or 
4-well slide chamber dishes. After attachment for 2-3 h, unattached cells were removed 
by multiple washes with sterile PBS. Cell culture was continued with addition of fresh 
medium supplemented with 10 nM E and 1 µM P.  
 
Co-culturing of blastocysts and stromal cells 
 
Female mice (CD-1) were sacrificed on day 4 of gestation and pre-implantation 
blastocysts were collected by flushing uterine horns and oviducts with sterile PBS. 
Blastocysts were cultured for ~24 h in 30 µl microdrops of M16 embryo culture medium 
(Sigma) under mineral oil, at 37°C in 5 % CO2. PSCs or immortalized Mouse Embryonic 
Fibroblasts (MEF) were plated into 2-well slide chamber dishes and grown in fresh 
medium (DMEM-F12A; with 100 unit/liter penicillin, 0.1 g/liter streptomycin, 1.25 
mg/liter fungizone, 2% heat-inactivated fetal bovine serum) supplemented with E and P 
as described above. After 24 h, unhatched blastocysts were carefully transferred onto 
confluent layers of PSCs or MEFs in culture dishes, at one 1 blastocyst per well. Co-
cultures were continued for up to 96 h and outgrowth was examined at various times 
during the culture period with an Olympus CKX41 inverted microscope and 
photographed. Embryo attachment was verified by gently shaking the culture dish. 
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Immunofluorescence staining for cytokeratin (CK) was performed post-fixation of co-
cultures as described below. The total area of embryo outgrowth and spreading was 
determined from CK-stained samples using Image J software analysis. The final value for 
each condition was derived from the average of 3-5 independent embryos.    
 
Adenoviral Transductions 
 
An adenoviral vector, expressing the dominant negative A-C/EBP mutant {{183 
Olive,M. 1996; }} and under the control of the CMV promoter, was a gift of Dr. Charles 
Vinson {{184 Bonovich,M. 2002; }}. Control adenoviral vectors lacking an A-C/EBP 
insert were also obtained from this source. Adenoviral stocks were purified using the 
Adeno-X™ Virus Mini Purification Kit (Clontech Laboratories Inc.). Concentrations of 
viral titers were determined in infective units/mL (Ifu/mL) using the Adeno-X™ Rapid 
Titer Kit (Clontech Laboratories Inc.). PSCs were infected with equal amounts of control 
or A-C/EBP adenoviral viruses at a multiplicity of infection (MOI) ranging from 2-60 
Ifu/cell. After 24 h of infection, cells were induced to differentiate in virus-free medium 
containing E and P as defined above.   
 
SiRNA transfections 
 
SiRNAs corresponding to mouse laminin !1 (AAAGGTGTTCAGGCGATTG), integrin 
"1 (TGCTTGTATACATTCTCCG) and negative control siRNAs that did not anneal to 
any specific target were pre-designed and synthesized by the Ambion siRNA delivery 
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resource (Ambion Inc.). Following isolation of PSCs and attachment for 3 h, annealed 
siRNA duplexes were transfected in the PSCs following the manufacturer’s protocol for 
siLentFect™ Lipid Reagent (Bio-Rad). Briefly, in 6-well plates, 4 µl of SiLentFect 
transfection reagent was mixed with 20-40 nM of siRNA duplexes in normal 
differentiation medium (containing E and P) to form complexes and dispersed. In 2- or 4-
well slide chambers, 2 ul of SilentFect transfection reagent was mixed with 20-40 nM of 
siRNA duplexes and dispersed. The transfection was repeated every 24 h. 
 
Real-time PCR analysis  
 
Total RNA was isolated from PSCs by standard Trizol-based protocols and converted to 
cDNA as described previously in Chapter 2. The cDNA was amplified by real-time PCR 
to quantify gene expression using gene-specific primers and SYBR® Green (Bio-Rad 
Laboratories). As a loading control, the expression level of the 36B4 gene, which encodes 
a ribosomal protein, was determined. For each treatment, the mean threshold cycle (Ct) 
and standard deviation were calculated from Ct values obtained individually from 3 to 4 
replicates of that sample. Each sample was subjected to three independent real-time PCR 
trials. Fold change was derived from the mean Ct values as described previously in 
Chapter 2. ANOVA single factor analysis was conducted on the grouped means to 
determine statistical significance at a significance level of P<0.05.   
 
The real-time PCR primer sequences are: C/EBP!, AGCGACCAGTACAAGATG 
(forward) and CTGCTCCACCTTCTT (reverse); laminin "1, 
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GATGACGCCGACCAGGAC (forward) and GCTGAGGAGGCTGCTGAC (reverse); 
laminin !1, CTGAGAGGCGGCTATGTGGAGATG (forward) and 
CTGCTGTTCTTGGTGGCGAATGTG (reverse); laminin !2, 
TGTATTGGAAGGTCTGGAAG (forward) and GGTCACACTCACATTCTTG 
(reverse); laminin !3, GAACTCCGCCTGGTGAAG (forward) and 
TGACTTGAGGTGGCAGAAC (reverse); laminin !4, CGCCAGGACAGCCAAGAAC 
(forward) and CGCAGGTCATCGGTCAAGTC (reverse); laminin !5, 
CTCTTCTATGACTTCGGCTCTG (forward) and CTCCACACGCACCAACAC 
(reverse); laminin "1, TGAATGCCTCCACCACAGACC (forward) and 
TCCTCCTGCTGCTCCTTGAAC (reverse); PRP, AGTCTGAACTCATCCTGCTTGG 
(forward) and TTGATGCAGCTTTCTCCCACAG (reverse); ALP, 
CATATAACACCAACGCTCAG (forward) and TGGATGTGACCTCATTGC (reverse); 
PR, AGCCAGCCAGAGCCCACAG (forward) and 
CCCACAGGTAAGCACGCCATAG (reverse); integrin !1, 
CAGCAGCCACTCCAGCAATG (forward) and GGATAACGGTGAGAAGCCAGATG 
(reverse); integrin !2, GGGACCTCACAAACACCTTCAG (forward) and 
GCTATGCCGAACCTCAGTATCTC (reverse); integrin !6, 
CTCTCGTTCTTCGTTCCAGGTTG (forward) and GCAGCAGCGGTGACATCTATG 
(reverse); integrin !7, AGCCACTGCCTAACATCTG (forward) and 
ACTTACTCCACTATCTCCATCC (reverse); integrin "1, 
AGTGAATGGCAACAATGAAGC (forward) and AATCAGCAGCAAGGCAAGG 
(reverse); integrin "3, TTGCTACTCTGCTCATCTGG (forward) and 
GCTCTGGCTCGTTCTTCC (reverse); 36B4, CTGCTGCCACCACTGCTG (forward) 
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and TCCTCATCTGATTCCTCCGACTC (reverse).  
 
Immunocytochemistry (ICC)  
 
Mouse PSCs and blastocysts were fixed (10% formalin) and blocked with a 5% solution 
of normal donkey serum (Jackson Immunoresearch) in PBS. Sections were incubated 
with the following primary antibodies diluted in blocking solution (5% NDS, sterile PBS) 
overnight at 4°C: laminin !1 (Chemicon & Abcam), laminin "1 (Chemicon), C/EBP# & 
ER" (Santa Cruz), PRP (Chemicon), integrin #1 (BD), integrin "6 (Abcam), phospho-
Tyr397 FAK (Cell Signaling Technology) and pan-Cytokeratin (Sigma-Aldrich). 
Samples were washed and incubated with biotin-, Cy3- and DyLight™488-conjugated 
secondary antibodies (Jackson Immunoresearch Laboratories Inc.) for 60 min. For PRP 
immunostaining, PSCs were incubated with avidin/biotin complex (Vectastain kit; Vector 
Laboratories Inc.) for 30 min and subsequently stained with DAB solution (Sigma 
Aldrich) and counterstained with 3% Methyl Green (Sigma). For immunofluorescence, 
counterstaining was done using 4’,6’-diamidino-2-phenylindole (DAPI; Invitrogen Inc.). 
Stained cells were mounted in Vectashield fluorescence mounting media (Vector 
laboratories Inc.). Negative controls included incubation with donkey serum and 
omission of the primary antibody for all samples. 
 
Image capture and quantitation of immunostaining  
 
The images of immunocytochemical staining were captured using an Olympus BX51 
model light microscope fitted with a Olympus DP71 digital camera (Olympus). In some 
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samples, fluorescent imaging was performed using a Leica DMR microscope and a 
Retiga EXI monochrome CCD camera (Qimaging). All images were processed using 
Adobe Photoshop CS version 8.0. 
 
Western Blotting 
 
Whole cell lysates were prepared from PSCs isolated from day 4 pregnant uteri. Whole 
cell lysates were subjected to Western blotting as previously described in Chapter 2 using 
primary antibodies directed against laminin !1 (Abcam), phospho-Tyr397 FAK (Cell 
Signaling Technology), ER" & calnexin (Santa Cruz Biotechnology). 
Chemiluminescence detection was performed using SuperSignal Femto and Pico reagents 
from Pierce (Thermo Scientific). 
 
Stromal cell membrane isolation and co-immunoprecipitation 
 
Membrane extracts were prepared from PSCs isolated from day 4 pregnant uteri and 
cultured for 72 h in the presence of E and P. Fractionation of cells into membrane and 
cytoplasmic fractions was carried out using a well-established protocol. Briefly, cells 
were homogenized using a non-denaturing lysis buffer C (20 mM HEPES, pH 7.9, 0.05% 
glycerol, 50 mM sucrose, 1.5 mM MgCl2, 20 mM KCl, 0.2 mM EDTA & 2x protease 
inhibitor cocktail (Roche)). Homogenates were centrifuged at 2000 rpm to separate nuclei 
from cell extracts. Remaining extracts were centrifuged at 45,000 rpm to separate 
membrane proteins from cytoplasm. Membrane proteins were resuspended in buffer M 
(20 mM HEPES, pH 7.9, 0.05% glycerol, 50 mM sucrose, 1.5 mM MgCl2, 20 mM KCl, 
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0.2 mM EDTA, 2x protease inhibitor cocktail & 1% sodium dodecyl beta-maltoside) and 
subjected to a well established immunoprecipitation protocol using monoclonal 
antibodies raised against integrin !1 (BD) or laminin "1 (Abcam). Immune complexes 
were recovered with protein A sepharose or protein G sepharose and separated by SDS-
PAGE (8%). A western blotting approach was used as described above using antibodies 
recognizing integrin !1 (BD) or laminin "1 (Abcam).   
 
Chromatin Immunoprecipitation (ChIP) 
 
The ChIP analysis was conducted using the EZ-ChIP kit (Upstate Biotechnology), 
according to the manufacturer’s protocol. Briefly, mouse PSCs were cultured for 24 h in 
medium supplemented with E and P, washed in PBS and cross-linked with 1% 
formaldehyde at room temperature for 10 min. The cross-linked cells were lysed using 
SDS-lysis buffer and sonicated 5 times for 10 sec each pulse. Lysates were precleared 
with salmon sperm DNA-protein A and the DNA-protein complexes were subsequently 
immunoprecipitated using antibodies against RNA polymerase II, rabbit IgG or C/EBP! 
(Santa Cruz Biotechnology). The immune complexes were recovered with protein A 
agarose. The beads were then repeatedly washed and protein complexes were eluted. The 
cross-linking was reversed and proteins were digested using 0.5 mg/ml proteinase K. 
Purified DNA were used as templates for real-time PCR using various primer sets to 
amplify specific regions of the E2F3 promoter. 
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In silico Promoter Analysis  
 
Putative C/EBP! binding sites at the Lamc1 promoter were determined by in silico 
analysis of the proximal promoter region (-1 bp to -1900 bp) using Consite (27) and 
TESS (28) softwares. Primers were designed to amplify specific regions containing 
putative C/EBP! binding sites as follows: -15bp to -23bp (5’-CTG TCA TTT AAC CGG 
GCA AG-3’ & 5’-AGG TCC GAA GAG GAG GAT GT-3’); -94bp to -105bp (5’-GGA 
TGT TCA AAG CGA GAT GA-3’ & 5’-ACC TGG GTA AGC GAT GAC AG-3’); -
499bp to -501bp (5’-GTA GCC ACC ACG GTC ACA TT-3’ & 5’-AGG ATC GGC 
CTC GGG ATA C-3’); and -1533 bp to -1544 bp (5’-CTG TCA TTT AAC CGG GCA 
AG-3’ & 5’-AGG TCC GAA GAG GAG GAT GT-3’) 
 
Statistical Analysis 
 
Statistical significance was assessed by ANOVA analysis at a significance level of P < 
0.05 and is indicated by an asterisk in the figures. NS indicates non-significant changes 
(P > 0.05). 
 
 
3.4. RESULTS 
 
 
 
Primary cultures of uterine stromal cells express classical basal lamina ECM 
molecules 
 
It was previously reported that in pregnant rodents uterine decidual tissue expresses high 
amounts of basal lamina ECM proteins such as laminins, collagen type IV and entactin 
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(9). In order to address the functional role of these unique basal lamina components in 
decidualization, we utilized a well-established in vitro model in which uterine stromal 
cells differentiate into decidual cells in response to E and P. We hypothesized that 
decidual cells derived from uterine stromal cells in vitro synthesize the same basal lamina 
ECM proteins produced in utero. To confirm this prediction, we measured the mRNA 
levels of several laminin genes that are reported to be expressed in vivo. We observed that 
the levels of laminins !1, "1 and "5 mRNAs were specifically and markedly induced 
during in vitro decidualization (Fig. 3.1 A). In contrast, the expression of laminin #1as 
well as several other laminin " subunits remained largely unchanged. Additionally, we 
showed that the decidual cells secreted high levels of laminin and collagen type IV 
proteins into the peri-cellular spaces (Fig. 3.1 B).  
 
Laminin !1 is a direct target of regulation by C/EBP#  in vivo 
 
We have previously demonstrated that C/EBP! is robustly induced during early 
pregnancy and controls decidualization of uterine stromal cells during implantation (19). 
A DNA microarray analysis conducted using WT and C/EBP#-null uterine stromal cells 
revealed that the expression of two laminin subunits, laminin !1 and laminin "1, is 
regulated by C/EBP# (Wang, W. unpublished). We confirmed this observation by 
measuring the mRNA levels of both laminin subunit genes in stromal cells isolated from 
WT and C/EBP# uteri subjected to an artificial decidual stimulus. The expression of 
laminin !1 and laminin "1 mRNAs was markedly reduced in C/EBP#-null uterine 
stromal cells collected from uteri after 48 h of decidual stimulation (Fig 3.2 A). Due to 
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the robust down-regulation of laminin !1 in C/EBP" null stromal cells, we investigated 
whether C/EBP" directly controls the expression of this gene. We examined the Lamc1 
promoter using in silico analysis and identified four putative binding sites for C/EBP" as 
indicated in Materials and Methods. We then performed chromatin immunoprecipitation 
(ChIP) analysis to examine C/EBP" occupancy at these sites. We discovered that there 
was significant recruitment of this transcription factor to the -94 region of the Lamc1 
promoter during differentiation of stromal cells (Fig 3.2 B).  
 
Inhibition of C/EBP! function impairs differentiation of primary uterine stromal 
cells in vitro 
 
In order to assess whether C/EBP! plays a critical role in uterine stromal cells subjected 
to differentiation in vitro, we employed a loss of function approach. A dominant negative 
mutant (A-C/EBP), previously constructed in Dr. Charles Vinson’s laboratory, forms a 
heterodimer with the endogenously expressed C/EBP! and prevents its interaction with 
the target genes (26). To block the transcriptional activities of C/EBP!, we introduced the 
A-C/EBP mutant into stromal cells via adenoviral infection methods. Using this strategy, 
we were able to efficiently suppress C/EBP!-mediated differentiation in uterine stromal 
cells infected with adenovirus at an MOI of 6:1 or more (Fig 3.3 A). This was evidenced 
by the dose-dependant reduction in mRNA levels of two well-characterized biochemical 
markers of decidualization, prolactin-related protein (PRP) and alkaline phosphatase 
(ALP). When a control adenovirus containing an empty adenoviral vector (Ad-CTRL) 
was used, no significant effect on PRP and ALP levels was observed (Fig 3.3 A).  As an 
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additional read-out of differentiation in vitro, we examined the morphology and 
cytoskeletal organization of stromal cells transduced with Ad-CTRL or A-C/EBP (Ad-
DN). In decidual cells, the actin cytoskeleton organizes into bundles of short to 
intermediate filaments that lie parallel to the long axis of the cell (18). When we labeled 
actin filaments with Alexa Fluor 488-conjugated phalloidin to visualize actin remodeling, 
cells transduced with Ad-CTRL showed significant cytoskeletal remodeling and appeared 
large, flattened and cuboidal-shaped, which are characteristics of decidualized cells (Fig 
3.3 B, left panel). In contrast, A-C/EBP-treated cells retained a relatively fibroblastic, 
undifferentiated phenotype and displayed a poorly formed, diffuse network of actin 
cytoskeleton (Fig 3.3 B, right panel). In control experiments, we ascertained that the 
levels of endogenous C/EBP! and estrogen receptor (ER") proteins remained unchanged 
in cells transduced with Ad-CTRL or A-C/EBP (Fig 3.3 C).   
 
C/EBP! regulates the expression of laminin "1 and laminin #1 in primary stromal 
cultures  
 
To examine whether the expression of laminin #1 and laminin "1  is regulated by C/EBP! 
in primary stromal cultures, we inhibited C/EBP! function using the A-C/EBP mutant as 
described previously. When we compared the mRNA levels of laminin #1 and laminin "1 
in cells transduced with Ad-CTRLor A-C/EBP, we found that there was a significant 
reduction in expression of both genes in A-C/EBP-treated cells at 24 h and 48 h of the 
differentiation process (Fig 3.4 A & B). We next examined the levels of laminin #1 and 
laminin "1 proteins. Both laminin subunits were deposited in a pericellular fashion by 
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stromal cells transduced with Ad-CTRL (Fig 3.4 C, panels a & c). We also observed a 
peri-nuclear deposition of both laminins, the significance of which is unclear to us. The 
expression levels of both laminin proteins were dramatically reduced when C/EBP! 
function was blocked by A-C/EBP (Fig 3.4 C, panels b & d). Collectively, these data 
suggested that laminin "1 and laminin #1 are both regulated by C/EBP! during 
differentiation of uterine stromal cells in vitro.  
 
Laminin !1 expression is critical for differentiation and cytoskeletal remodeling of 
uterine stromal cells 
 
The regulation of laminin !1 by C/EBP! in uterine stromal cells raised the possibility that 
this ECM molecule is important for the process of decidualization. Fifteen laminin 
heterotrimers are known to arise from combinations of single #, ! and " subunits (11, 13, 
14). Laminin "1 is uniquely shared among 10 out of 15 of these combinations, making it 
a key subunit for laminin assembly. Furthermore, the Lamc1 null mutation in mice was 
peri-implantation lethal due to a failure in embryonic basement membrane formation 
(16). Therefore, it is critical to examine the role of this important laminin gene in 
decidualization. We began by testing whether siRNA-mediated silencing of Laminin "1 
expression would affect the process of differentiation and cytoskeletal remodeling. This 
approach would effectively eliminate assembly of all ten laminin !1-containing trimers in 
the basement membrane.  
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Uterine stromal cells were transfected with scrambled siRNA (siCTRL) or siRNA 
targeted to exon 3 of the laminin !1 transcript (siLAMC1). The levels of laminin !1 
mRNA and protein were efficiently down-regulated (>80%) upon administration of 
siLAMC1 (Fig 3.5 A, upper & lower panels). Interestingly, this reduction in laminin !1 
expression caused mRNA levels of two decidual biomarkers, PRP and ALP, to decline by 
~50% (Fig 3.5 C), while the levels of C/EBP", ER# and progesterone receptor (PR) 
remained unaffected, (Fig 3.5 B). The decline in the level of PRP mRNA was also 
accompanied by the reduction in the level of the corresponding protein in siLAMC1-
treated cells (Fig 3.5 D). The down-regulation of PRP and ALP is a strong indication that 
differentiation of stromal cells is impaired when laminin !1 expression is decreased.  
 
Concomitant with the decrease in differentiation markers, we also observed that the actin 
cytoskeleton is disrupted when we attenuated laminin !1 expression. The actin 
cytoskeleton was disorganized in siLAMC1-treated cells as compared to the siCTRL-
treated cells (Fig 3.5 E, panels c & f). Additionally, the overall morphology of siLAMC1-
treated cells was not representative of the typical decidual phenotype (Fig 3.5 E, panel f). 
Collectively, these observations indicated that the siRNA-mediated attenuation of laminin 
!1, a critical component of the uterine basement membrane, perturbs the process of 
decidualization. To test whether we could rescue the loss of a decidual phenotype after 
laminin !1 knockdown, uterine stromal cells were treated with recombinant laminin-1 
(Laminin !1"1#1), following siRNA treatment. Upon addition of laminin-1, PRP and 
ALP mRNA levels could be recovered in a dose-dependent fashion in siLAMC1-treated 
cells (Fig 3.5 F, panels b & c).  
! "#!
 Decidual cells express integrin !1 receptors, which interacts with laminin "1 during 
decidualization 
 
The integrin family of receptors serve as receptors for laminin in the cell membrane (11, 
29, 30). The ! and " subunits of integrins form heterodimers, which transmit signals from 
the ECM to the cytoplasm. This is made possible through adhesive interactions between 
integrin receptors and the ECM, and is largely mediated by laminin polymers positioned 
on the cell membrane. , We hypothesized that the laminins deposited around the decidual 
cells interact with integrin receptors to activate intracellular signaling pathways.  
 
Integrin !1 is the most prevalent integrin subunit among all reported laminin receptors in 
the basement membrane (11, 31). When we examined the levels of integrin "1 protein in 
decidual cells, we found that its localization on the cell membrane (Fig 3.6 B, panels a & 
b) coincided with sites of focal adhesions indicated by F-actin staining in the same cells 
(Fig 3.6 B, panels c & d). To identify the integrin alpha subunit that potentially partners 
with integrin "1 on decidual cell surface, we analyzed the expression levels of several 
alpha integrins known to interact with integrin !1 and laminin. We found that the 
mRNAs corresponding to integrins !2 and !6 were significantly up-regulated (Fig 3.6 A). 
Like integrin !1, integrin "6 was expressed at the cell periphery and in the cytoplasm of 
differentiating stromal cells (Fig 3.6 B, panels e & f). Based on these observations, it is 
likely that integrin "2!1 and/or "6!1 are the membrane receptors for laminins during 
decidualization. To directly test whether laminin #1 and integrin "1 co-exist in a complex 
at the cell membrane, we employed a coimmunoprecipitation approach. Using non-
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denatured membrane extracts prepared from decidual cells after 72 h of differentiation, 
we performed immunoprecipitations for either integrin !1 (Fig 3.6 C, panel a) or laminin 
"1 (Fig 3.6 C, panel b) and then assessed the presence of each protein in the 
coimmunoprecipitate. We confirmed by Western blotting that both integrin !1 and 
laminin "1 are present in a complex formed at the cell membrane of decidual cells (Fig 
3.6 C, arrows).       
 
The interaction between laminin !1 and integrin "1 is important for stromal 
differentiation  
 
To test whether an association between the laminin ECM and integrin !1 complex is 
necessary for decidualization, we utilized two different loss-of-function approaches. In 
the first approach, cells were treated with the disintegrin, echistatin, a potent antagonist of 
integrin !1 or !3 binding to ECM (32). Treatment with a non-toxic dose of this inhibitor 
significantly impaired stromal differentiation (Fig 3.6 D). Actin cytoskeleton remodeling 
was defective in echistatin-treated cells, and the typical morphology of the decidual cells 
failed to appear. In parallel experiments, BSA-treated cells displayed cellular architecture 
characteristic of the decidual phenotype. Additionally, the levels of the differentiation 
marker, PRP, were reduced upon echistatin treatment (Fig 3.6 E). In the second approach, 
we silenced integrin !1 expression with a siRNA targeted to its transcript. This 
intervention led to a moderate decrease in the levels of both differentiation markers, PRP 
and ALP (Fig 3.6 F). Collectively, these data indicated that when integrin !1 function is 
abrogated, stromal differentiation and actin remodeling are impaired. We postulate that 
! "#!
the lack of laminin- integrin interactions at the stromal cell membrane contributes to this 
defect.  
 
Downstream signaling pathways are disrupted when laminin !1 is silenced in 
decidual cells 
 
To further test our hypothesis that the association between the laminin-containing ECM 
and the integrin !1 complex at the stromal cell surface is important for decidualization, 
we examined the activation of a classical integrin-dependent signaling molecule, focal 
adhesion kinase (FAK). Among a diverse set of intracellular signaling molecules that are 
modulated by integrin receptors, FAK is a prominent target, making it an obvious 
candidate for further investigation in decidual cells (33, 34). FAK is activated through 
phosphorylation of multiple residues, of which a major one is Tyr397. We first examined 
the levels of phospho-Tyr397-FAK in decidual cells treated with either siCTRL or 
siLAMC1. While control cells displayed a typical punctuate distribution of phospho- 
Tyr397-FAK at the cell membrane (Fig 3.7 A, panel a, arrows), the levels of phospho- 
FAK were significantly reduced in cells where laminin !1 is silenced (Fig 3.7 A, panel b). 
This finding was confirmed by Western blotting of decidual cell lysates collected at 
various times following siRNA treatment (Fig 3.7 B). The levels of ER", an important 
decidual factor, did not change with either siRNA treatment. These observations suggest 
that FAK activation is dependant on the accumulation of the laminin ECM and its 
interaction with integrin in decidual cells.  
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Co-culture of pre-implantation blastocysts with uterine stromal cells 
 
The process of embryo implantation is highly dependant on the ability of uterine stromal 
cells to differentiate and interact with the invading trophoblasts. The current thinking is 
that factors such as ECM proteins, produced and secreted by the decidua, assist in the 
establishment of a maternal-fetal interphase that ultimately leads to formation of the 
uterine vasculature (5, 6). It is challenging to fully decipher the molecular mechanisms 
underlying this complex in vivo process, necessitating the use of in vitro models to 
replicate the process of implantation (5, 22, 23). In order to recapitulate the process of 
embryo invasion into the decidua, we employed an in vitro strategy of co-culturing 
blastocysts and primary uterine stromal cells (Fig 3.8 A). Using this approach, we were 
able to monitor the outgrowth of embryos by examining the migration of the outer 
trophoblast cell layer into the surrounding decidual cell layers (Fig 3.8 B & C). We 
documented the outgrowth of the embryo at regular intervals for approximately 80 h and 
observed that viable blastocysts placed on a confluent bed of stromal cells (Fig 3.8 B, 
panels i & ii) underwent hatching, as evidenced by the shedding of the protective zona 
pellucida (Fig 3.8 B, panel ii), and attached to the bed of stromal cells by 21 h of co-
culture (Fig 3.8 B, panel iii). The attached embryos continued to spread steadily, as 
evidenced by the increase in overall area of the embryonic tissue (Fig 3.8 B, panels IV-
VI). Between 51 h and 80 h of co-culture, embryo outgrowth was especially prominent, 
as evidenced by the extent of trophoblast migration into the surrounding decidual cells 
(Fig 3.8 B, panels v and vi). To further define embryo outgrowth, we monitored the 
spreading of trophoblast cells using antibodies against cytokeratin, an established 
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biochemical marker of the trophoblast cell layer (Fig 3.8 C). We observed that 
cytokeratin-positive trophoblasts migrate away from the embryo and penetrate into the 
uterine stromal cells over time (Fig 3.8 C, arrows). After 72 h of culture, the migrating 
trophoblasts closely interfaced with stromal cells (Fig 3.8 C, panel b) and this 
phenomenon persisted until 96 h of co-culture (Fig 3.8 C, panel c). Collectively, these 
observations suggested that the co-culturing of maternal and embryonic cells is likely to 
recapitulate the fundamental aspects of embryo implantation in the mouse. We then 
utilized this model to understand the functions of C/EBP! -mediated basal lamina in 
embryo implantation.   
 
Embryo spreading is most efficient on ECM synthesized by decidual cells 
 
 It is thought that embryo outgrowth is dependent on interactions between the trophoblast 
and the laminin-based ECM produced by the decidualized uterine stromal cells. To 
determine the specificity of embryo spreading on a decidual ECM, we compared the 
efficiency of different substrates in promoting embryo spreading. When cultured on glass 
surface without any matrix coating, blastocysts were able to attach but did not spread (Fig 
3.9). However, when placed on undifferentiated mouse embryonic fibroblasts (MEF), 
blastocysts showed a modest amount of spreading. We next tested embryo outgrowth on 
various ECM substrates (Fig 3.9). On plates coated with laminin alone, the spreading was 
about ~40% as effective as on decidual cells (Fig 3.9). We found that collagens type I and 
type IV are more effective than laminin in promoting embryo spreading and about twice 
as effective as fibronectin in promoting outgrowth (Fig. 3.9). However, embryo 
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outgrowth on a collagen IV-coated surface was ~70% as effective as on decidual cells. 
Finally, we tested embryo outgrowth on matrigel, a solubilized tissue basement 
membrane substrate containing laminins, collagen type IV, entactin and heparan sulfate 
proteoglycan. Surprisingly, this combination of ECM molecules was only ~60% as 
effective as the decidual cells (Fig 3.9). These data strongly suggested that embryos 
develop and spread most effectively on the ECM of fully decidualized stromal cells.  The 
absence of properly reconstituted ECM limits embryo outgrowth. Collectively, these data 
suggested that decidual cells synthesize a full complement of ECM components that 
effectively support embryo penetration. 
 
Blockade of C/EBP! function in stromal cells prevents embryo spreading and 
trophoblast invasion 
 
We previously demonstrated that C/EBP! function is critical for uterine stromal 
decidualization (Fig 3.3). We next tested the hypothesis that C/EBP!-mediated 
differentiation of stromal cells is important for supporting trophoblast outgrowth in our 
co-culture model. First, we blocked C/EBP! activity in differentiating stromal cells by 
introducing the dominant negative mutant, A-C/EBP. Following pre-treatment of stromal 
cells with Ad-CTRL or A-C/EBP (Ad-DN), we placed unhatched, preimplantation-stage 
blastocysts on to pre-treated stromal cells. We then closely monitored embryo hatching, 
attachment and spreading over time. After 48 h of co-culture, blastocysts grown on Ad-
CTRL–treated cells exhibited an efficient penetration of trophoblasts into the decidual 
cells, resulting in embryo spreading (Fig 3.10 A, panel a). However, blastocysts grown on 
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stromal cells in which C/EBP! function is inhibited by Ad-DN displayed significantly 
diminished trophoblast penetration and embryo outgrowth (~60%) (Fig 3.10 A, panel b). 
These differences were quantified across five independent experiments by measuring the 
overall area of embryo outgrowth (Fig 3.10 A, panel c). These data served as a proof of 
principle that the maternal contributions to embryo implantation can be studied in this co-
culture model by manipulation of gene function in stromal cells.  
 
Disruption of stromal basal lamina-like ECM inhibits embryo spreading and 
trophoblast migration 
 
We next investigated whether trophoblast migration and embryo spreading are affected 
by altering the assembly of basal lamina-like ECM in stromal cells. Stromal cells were 
transfected with control siRNA or siLAMC1 targeting the laminin "1 mRNA prior to co-
culturing them with blastocysts. Following placement of blastocysts on siRNA-treated 
cells, the co-cultures were monitored for 48 h after which they were fixed and analyzed 
for embryo outgrowth and trophoblast migration. Blastocysts grown on cells treated with 
control siRNAs displayed an expected extent of spreading and trophoblast penetrance 
into the decidual cells (Fig 3.10 B, panel a). In contrast, blastocysts displayed a 
pronounced reduction in spreading when placed on stromal cells in which laminin "1 was 
silenced by siLAMC1 (Fig 3.10 B, panel b). This observation was repeated in five 
independent experiments and the embryo spreading was quantified. The results revealed 
that blastocysts cultured on siLAMC1-treated stromal cells were spreading ~60% less 
efficiently than on cells treated with control siRNA (Fig 3.10 B, panel c). Collectively, 
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these results demonstrated the importance of the basal lamina-like stromal ECM in 
promoting embryo growth and trophoblast migration.    
 
 
3.5. DISCUSSION 
 
 
The process of endometrial remodelling during implantation involves the differentiation 
of stromal cells, establishment of maternal vasculature and a remarkable transformation 
of the ECM within the stromal compartment. In this study, we have attempted to shed 
new insights into the role of the uterine basal lamina in implantation by utilizing in vitro 
approaches. We have established a novel molecular link between C/EBP!, a major 
regulator of endometrial function, and laminin synthesis in uterine stromal cells. We 
demonstrated that when laminin synthesis is interrupted, uterine stromal differentiation is 
perturbed due to morphological and biochemical defects. We further showed that 
C/EBP! and laminin are both critical for embryo invasion into decidual cells in vitro.     
 
C/EBP!  is an important regulator of uterine stromal differentiation and stromal 
ECM remodeling.  
 
Upon embryo penetration into the uterus, fibroblastic stromal cells transform into 
morphologically and biochemically distinct decidual cells that synthesize large amounts 
of basement membrane ECM molecules. Previous reports have documented that 
coincident with decidua formation, the formation of a unique basal lamina-like ECM, 
containing laminin "1, laminin #1 and collagen type IV #2 subunit, was markedly 
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induced (8-10). The expression of these molecules appeared to spread throughout the 
decidual zone. They were assembled into a peri-cellular ECM network, which surrounded 
the invading embryo. Laminin !1, in particular, was ubiquitously expressed throughout 
the entire decidual transformation (10). Because of the unique setting of this basement 
membrane ECM in the uterine tissue, it is plausible that a major function of this ECM is 
to support the differentiation of uterine stromal cells. Another possibility is that the 
uterine basal lamina provides the guidance cues that an embryo needs in order to implant 
correctly in the uterus (5, 10). In this study, we focused our efforts in understanding the 
role of C/EBP" in stromal basal lamina formation. C/EBP" regulates the expression of 
laminin !1 and laminin #1 and is recruited to the Lamc1 promoter during stromal 
differentiation (Fig 3.1). Furthermore, the expression levels of both laminin !1 and 
laminin #1 were down-regulated upon blockade of C/EBP" function (Fig 3.4). 
 
These observations are consistent with the notion that ECM production by decidual tissue 
is a highly regulated process. Indeed, it is well known that steroid hormones induce 
stromal cells to produce paracrine factors that drive decidualization and regulate ECM 
synthesis and secretion. However, to date, the gene regulatory mechanisms controlling 
the production of this ECM and its function have remained unclear. Our study indicates 
that the steroid hormone-regulated production of the basal lamina-like ECM is mediated 
via C/EBP". We demonstrated that uterine stromal cells failed to differentiate adequately 
in vitro when C/EBP" function is inhibited (Fig 3.3). Gene expression profiling of wild 
type and C/EBP"-null stromal cells has led to the identification a subset of genes 
involved in stromal ECM formation during decidualization. These data, together with our 
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microarray findings, are the first demonstration that C/EBP! regulates ECM production 
during stromal differentiation. The contribution of this unique decidual ECM to the 
differentiation process is likely to be an important aspect of uterine functions. To 
specifically test this concept, we investigated the role of laminin "1 in uterine stromal 
differentiation.  
 
 
Laminin "1 is a critical component of the stromal basal lamina-like ECM and is 
necessary for decidualization.  
 
The basement membrane is a highly specialized and complex structure that interacts with 
cell surfaces within a wide variety of mammalian tissues. Previously thought to be an 
inert structure, the basement membrane has been receiving more attention recently due to 
its dynamic regulatory roles in a variety of cellular processes such as proliferation, 
differentiation, morphogenesis and apoptosis (11, 36, 37). Several lines of evidence have 
indicated that laminin heterotrimers (#x!x"x) catalyze the assembly of basement 
membranes (11, 38). The laminins polymerize with other laminin heterotrimers through 
their NH2-terminal arms, forming a continuous layer upon which collagen type IV, 
nidogen, entactin and perlecan assemble (36). Furthermore, the genetic ablation of the 
laminin !1 gene, an essential laminin subunit in most of the laminin heterotrimers, leads 
to failures in embryonic differentiation, embryonic tissue organization and Schwann-cell 
differentiation (16, 37, 39). Previous reports also showed that trimeric laminins could 
only acquire full functionality upon the assembly of laminin # chains with their ! and " 
chain partners (42). These observations underline the pivotal role of laminin "1 in basal 
lamina formation and further emphasize the importance of this ECM structure in diverse 
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cellular processes. In the present study, we have used a uterine stromal cell culture 
system to uncover the role of laminin !1 and the basal lamina-like matrix in stromal 
decidualization. When we silenced laminin !1 gene expression by RNAi, we observed 
that uterine stromal cells were unable to differentiate properly into decidual cells (Fig 
3.5). This defect was characterized by severe morphological abnormalities in stromal 
cells, a failure in actin cytoskeletal remodeling and a reduction in the levels of classical 
biochemical markers of decidualization. When laminin-1 ("1#1!1) was added 
exogenously to cells in which laminin !1 was silenced, stromal differentiation was 
partially rescued, as measured by the recovery of PRP and ALP levels (Fig 3.5). This 
result further underscored the importance of laminins in uterine stromal differentiation. 
Collectively, these observations support the concept that the assembly of the basal 
lamina-like ECM is critical for stromal differentiation. In previous reports by Klaffky et 
al. and Miner et. al., the composition of laminins in the uterine basal lamina was 
surveyed during the early post-implantation period. It was observed that laminins "5, #1 
and !1 were especially enriched in the decidualized stromal matrix (40, 41). These studies 
concluded that the laminin heterotrimers present at the onset of implantation are laminins 
10 and 11. Most strikingly, both of these trimeric laminins contain laminin !1. We have 
also observed that laminin "5, a subunit of laminins 10 and 11, is expressed in decidual 
cells and its spatiotemporal expression overlaps with that of laminin !1 (Fig 1, data not 
shown). We postulate that the production of laminins !1 and "5 during stromal 
differentiation may permit formation of laminins 10 and 11 by decidual cells. Therefore, 
in the context of earlier observations, our findings are supportive of an important role for 
laminin !1 in in vitro stromal differentiation. 
! "#$!
Signaling mechanisms controlled by laminins during decidualization. 
 
Laminins in the basal lamina ECM interact with membrane-bound receptors, such as 
integrins, to modulate intracellular signaling pathways and influence cell behavior. There 
is considerable redundancy among the potential integrin receptors for laminins in the 
basement membrane. However, integrin !1 is the most abundant subunit among the 
laminin-interacting integrin receptors (11). Based on the previously published reports that 
differentiating uterine stromal cells synthesize laminins 10 and 11, we reasoned that these 
laminins serve as ligands for integrin receptors present on the cell membranes to drive 
stromal differentiation. A survey of the expression levels of the individual integrin 
subunits that are able to interact with these two laminin trimers predicted that integrin 
subunits "1, "2, "6 and !1 are likely to be the candidate laminin-binding components on 
the decidual cells (Fig 3.6). These integrin subunits can dimerize into active integrin "! 
membrane-bound receptors ("1!1/"2!1/"6!1) (11). Laminin heterotrimers will then 
interact with integrin heterodimers via the globular tail domains present in the laminin " 
chain. Based on the abundance of integrin "6 and !1 proteins in decidual cells (Fig 3.6 
A), and in accordance with previous literature, we propose that integrin "6!1 is a major 
receptor for laminin (30). To support this notion, we have demonstrated via co-
immunoprecipitation studies that laminin #1-containing laminins interact with integrin !1 
on decidual cell membranes (Fig 3.6 C). Specifically, we propose that laminin #1 
heterotrimerizes with laminin "1 or "5 chains and that the association with integrin !1 is 
mediated by the globular domain of the alpha chains. On a functional level, the inhibition 
of laminin-integrin interactions by echistatin, or the silencing of integrin !1 expression 
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resulted in the loss of differentiation of stromal cells. These findings nicely correlate with 
integrin !1’s proposed role as a laminin receptor. Additionally, mice carrying deletions in 
integrin !1 or laminin "1 are both peri-implantation lethal due to failures in embryonic 
basement membrane formation, suggesting a strong connection between the functions of 
these two proteins (16, 43, 44). The impairment in decidual phenotype observed upon 
interruption of laminin "1 or integrin !1 function in stromal cells is further evidence that 
this integrin subunit is required for proper laminin assembly and function.   
 
We also demonstrated that an attenuation of laminin "1 function resulted in the down-
regulation of FAK activity (Fig 3.7). FAK is a critical component of the integrin-
mediated signaling network. Upon activation by phosphorylation, it is responsible for the 
modulation of actin remodeling via Src kinase and/or MAP kinase pathways in various 
cell types (31, 33, 34). We propose that the association of laminin and integrin  triggers 
FAK activation that permits actin remodeling. Coincidentally, the localization of integrin 
!1 on decidual cells closely overlaps with sites of actin bundling and focal adhesion 
formation (Fig 3.6 B). When we interrupted laminin "1 expression in uterine stromal cells 
by RNAi, we also disrupted laminin-integrin interaction. As a result, FAK activation was 
inhibited and stromal cells were unable to assemble actin cytoskeleton properly, failing to 
form focal adhesions. Therefore, our studies uncovered a signaling mechanism by which 
stromal ECM containing laminin "1 transmits information to the interior of the cell via 
the integrin receptor. It was proposed previously that as cells synthesize increasing 
amounts of laminin, cooperative interactions between laminin and integrin receptors are 
strengthened and promote cytoskeletal re-organization to instruct cell behavior (36). We 
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hypothesize that a similar ECM-driven transformation  occurs in differentiating uterine 
stromal cells during the decidualization process. 
 
Laminin plays a vital role in mediating maternal-fetal interactions during 
implantation.  
 
From our experiments involving co-cultures of blastocysts and uterine stromal cells, we 
have obtained three major insights. First, we were able to show that placement of pre-
implantation blastocysts with differentiating uterine stromal cells successfully 
recapitulates certain aspects of the in vivo implantation, such as embryonic growth and 
trophoblast migration. Second, we demonstrated that C/EBP!-mediated differentiation of 
stromal cells is critical for embryo spreading and penetration into these cells. The loss of 
C/EBP! funtion in stromal cells, in addition to its profound effect on decidualization, 
appears to affect the ability of trophoblasts to invade into and interact with the stromal 
matrix. Finally, our studies have revealed that basal lamina in the stromal ECM plays a 
critical role, in modulating embryo spreading and invasion.  
 
It was proposed by several groups that the uterine basement membrane is a major 
facilitator of maternal-fetal interactions during the post-implantation phase. By directly 
interacting with the mural trophoblast layer of the blastocyst, the laminins and collagen 
IV networks in the decidualized matrix modulate trophoblast migration and infiltration 
into the stromal compartment (5, 22). During these events, trophoblast cells express 
integrin receptors, such as integrin "7!1, which are the primary embryonic receptors for 
! "#$!
the laminin trimers present in the uterine basement membrane (40). A majority of these 
predictions were confirmed through the use of in vitro models in which blastocysts were 
cultured on surfaces coated with laminin, collagen IV or fibronectin and subsequently, 
trophoblast behavior was assessed. To add to these studies, we analyzed peri-
implantation events by examining how blastocysts behave when cultured together with 
differentiating stromal cells harvested from the same uterine tissue (Fig 3.8). This 
approach was previously utilized when human endometrial stromal cells were 
differentiated and grown together with blastocysts (45, 46).  
 
A major challenge in the field is to decipher the mechanisms by which the trophoblasts 
adhere to and interact with uterine stromal ECM proteins. We reasoned that as 
differentiation progressed, stromal cells would secrete laminin !1 and other basal lamina 
components into the pericellular space, allowing for their direct contact with mural 
trophoblast cells of the blastocyst. As a result of this intimate interaction, a reciprocal 
relationship is established between decidual cells and the embryo, permitting trophoblast 
invasion into the decidual cells and the advancement of both the decidual and embryonic 
development programs (5, 6). In support of this concept, we observed that if we inhibit 
stromal differentiation by blocking the function of C/EBP", the trophoblast cells do not 
receive the maternal signals that allow them to acquire an invasive behavior (Fig 3.10A). 
We interpreted this defect as a cumulative outcome of several molecular mechanisms 
disrupted by the blockade of C/EBP" function. The interruption of C/EBP"-regulated 
laminin !1 synthesis would result in defective basement membrane formation and the loss 
of an intimate association between trophoblasts and decidual cells. Our results confirmed 
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this idea when we silenced laminin !1 expression and witnessed a significant loss of 
embryo spreading and trophoblast invasion (Fig 3.10 B & C). Collectively, our studies 
regarding the role of laminin !1 in embryo invasion provide novel mechanistic insights 
about how trophoblasts interact with uterine cells. Furthermore, our results provide a 
view of the interactions observed between trophoblasts and uterine ECM in vitro, which 
would likely correspond to interactions observed between invading trophoblast giant cells 
and decidua in vivo. It will be of further interest to understand how the laminins in the 
stromal basement membrane interact with integrin receptors in the embryo.   
 
The uterine basement membrane is a complex mixture of ECM proteins and the 
contribution of each component to embryo invasion is of tremendous interest. A study by 
Sutherland et. al. showed that when blastocysts were placed on culture plates coated with 
laminin or collagen or fibronectin, they displayed fairly similar patterns of outgrowth and 
spreading (23). Our studies showed that blastocysts adhered to and spread on a 
decidualized stromal matrix most efficiently, followed by collagen type IV-coated 
surfaces. They also showed a moderate ability to spread on laminin-1 alone or on 
Matrigel, which resembles a basal lamina type of ECM  (Fig 3.9). Our studies are 
generally in agreement with previous reports by Sutherland et. al., describing the 
spreading of blastocysts on collagen IV and laminin. Most interestingly, blastocysts did 
not spread very effectively when placed on proliferating mouse embryonic fibroblasts 
(MEF), underlining the requirement for specific maternally-derived matrices or signals to 
modulate embryo invasion.  
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In conclusion, this study shows that uterine stromal cells undergo decidualization, 
producing a unique basal lamina-like ECM. This process is controlled by the steroid 
hormone-regulated factor, C/EBP!. Our study has uncovered a novel mechanism by 
which C/EBP! regulates the assembly of the stromal basement membrane by controlling 
the synthesis of laminin "1, a critical component of this structure. Our results further 
demonstrated that the basal lamina-like ECM containing laminin "1 has multiple 
functional roles during decidualization. It controls stromal differentiation and the 
accompanying cellular architecture necessary for decidualization. It is also a key 
regulator of the critical interactions between maternal and fetal tissues during 
implantation. In the future, it would be important to develop mouse models with uterus-
specific mutations in various ECM components in the stroma to precisely delineate the 
mechanisms that regulate maternal-fetal interactions during pregnancy.      
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3.7.  FIGURES AND LEGENDS 
 
FIG. 3.1. 
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Figure 3.1 Uterine decidual cells express basal lamina ECM in vitro 
 
PSCs were isolated from pre-implantation day 4 (D4) pregnant mouse uteri, plated for  
3 h and subsequently differentiated with E and P for 24, 48 and 72 h.  
 
 
A. After E and P treatment, total RNA was isolated for real-time PCR analysis. Relative 
expression levels of laminins !1, a1, a2, a3, a4, a5 and "1 mRNAs were determined. 
The fold changes for each timepoint indicate gene expression relative to 24h E+P-
treated-PSC. 
 
B.. Cells were fixed after 48 h of E and P treatment and subjected to 
immunofluorescence using antibodies recognizing all laminins (Pan-Laminin) and 
Collagen type IV (Collagen IV).  
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FIG. 3.2. 
 
Figure 3.2. C/EBP!  regulates laminin "1 and #1 during uterine stromal 
differentiation 
 
A. WT and C/EBP!-null mice were subjected to artifical decidualization protocol as 
described in Materials and Methods. Uteri were collected after 48 h after decidual 
stimulation and primary stromal cells (PSC) isolated as described in Materials and 
Methods. Total RNA was analyzed by real-time PCR using specific primers against 
laminin "1 (Lamc1) and laminin #1 (Lama1). The fold changes indicate gene expression 
levels in C/EBP!-null cells (KO) relative to wild-type (WT) cells. Statistically significant 
differences (P<0.05) are indicated by *.   
 
B. ChIP analysis: PSCs were isolated from pre-implantation day 4 (D4) pregnant mouse 
uteri, plated for 3 h and subsequently differentiated with E and P for 24 h. ChIP was 
performed as described in Materials and Methods using antibodies against C/EBP!, 
RNA polymerase II (RNAP II) and rabbit IgG. Relative levels of recruitment at various 
sites on the Lamc1 promoter were determined by real-time PCR and normalized to input 
DNA and RNAP II values. 
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FIG. 3.3. 
 
 
 
 
Figure 3.3. C/EBP!  regulates uterine stromal cell differentiation 
 
PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then 
transduced with adenovirus particles carrying either an empty vector (Ad-CTRL) or a 
vector expressing a dominant negative mutant of C/EBP!, A-C/EBP (Ad-DN) for 24 h. 
Adenoviral treatment was conducted at MOIs of 0, 6, 12, 25, 50 and 60 as described in 
Materials and Methods. After adenovirus removal, PSC were treated with E and P for  
72h and total RNA isolated for real-time PCR analysis.  
 
A. Relative expression levels of PRP and ALK-P mRNAs were determined. The relative 
fold change for each adenoviral treated sample is represented as compared to PSC 
treated with an MOI of 0.  
 
B. Cells were fixed and subjected to immunofluorescence using Alexa-fluor-Phalloidin to 
label actin filaments (F-actin). DAPI-stained nuclei are shown in blue. C. Cells were fixed 
and subjected to immunofluorescence using antibodies recognizing C/EBP! and ER". 
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FIG. 3.4. 
 
 
 
Figure 3.4. C/EBP!  regulates the synthesis and secretion of laminins "1 and #1 
during stromal cell differentiation 
 
PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then 
transduced with adenoviral particles carrying either an empty vector (Ad-CTRL) or a 
vector expressing a dominant negative mutant of C/EBP!, A-C/EBP (Ad-DN) for 24 h. 
After adenovirus removal, PSC were treated with E and P for 24, 48 and 72 h and total 
RNA isolated for real-time PCR analysis using primers specific to laminin "1, A, and 
laminin #1, B.  
 
C. Alternatively, after adenovirus removal, PSC were treated with E and P for 48 h and 
subsequently fixed and subjected to immunofluorescence using antibodies recognizing 
laminin "1 and laminin #1.  
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FIG. 3.5. 
                                                           
 
 
Figure 3.5. SiRNA-mediated silencing of laminin !1 expression inhibits stromal 
differentiation and cytoskeletal remodeling. 
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Figure 3.5. continued: 
 
PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then 
transfected with 20 nM negative control siRNAs (siCTRL) or siRNAs targeted against 
laminin !1 (siLAMC1) as described in Materials and Methods.  
 
A, Upper After 48 and 72 h, total RNA was collected and real-time analysis was 
conducted using primers specific to laminin !1. Fold changes indicate gene expression 
levels in siLAMC1-treated PSCs relative to siCTRL-treated PSCs. Lower, Western 
blotting analysis of laminin !1 protein levels in whole-cell lysates prepared from PSC 
isolated from D4 pregnant uteri, and from siRNA-transfected PSC after 24, 48 and 72 h.  
 
B. Real-time analysis of C/EBP", ER# and PR mRNA levels at 72 h, using RNA 
collected from PSCs transfected with siCTRL or siLAMC1. 
 
C. Real-time analysis of PRP and ALP mRNA levels at 72 h, using RNA collected from 
PGCs transfectd with siCTRL or siLAMC1. 
 
D. SiRNA-treated PSCs were fixed after 72 h of transfection and subjected to 
immunocytochemical analysis to monitor PRP protein levels.  
 
E. PSCs were transfected with siCTRL or siLAMC1 for 48 h, fixed and subjected to 
immunofluorescence analysis using an antibody recognizing laminin !1 (panels a & d). 
DAPI-stained nuclei are shown in blue (panels b & e). Actin filaments (F-actin) were 
labeled with Alexa-fluor-phalloidin (panels c & f).  
 
F. PSCs were transfected with siCTRL or siLAMC1 for 48 h following which siRNAs 
were removed and stromal culture continued in the absence or prescence of 2.4 ug/mL 
and 24 ug/mL of recombinant laminin-1 for an additional 24 h as described in Materials 
and Methods. Total RNA was collected and subjected to real-time PCR using primers 
specific to laminin !1 (panel a), PRP (panel b) and ALP (panel c). 
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FIG. 3.6. 
 
 
 
 
Figure 3.6. Differentiating stromal cells express integrins receptors for laminin !1 
 
PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then treated 
with E and P for 24, 48 and 72 h.  
 
A. Total RNA was collected at each timepoint for real-time PCR analysis using primers 
specific to integrin "1, integrin "2, integrin "6, integrin "7 and integrin #3. Fold changes 
indicate relative gene expression levels at each timepoint relative to 24 h.  
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Figure 3.6. continued: 
 
B. E and P-treated PSC were fixed and subjected to immunofluorescence analysis using 
antibodies recognizing integrin !1 (panels a & b) and integrin "6 (panels e and f). Actin 
filaments (F-actin) were labeled with Alexa-fluor-phalloidin (panels c & d). DAPI-stained 
nuclei are shown in blue. 
C. PSC were treated with E and P for 72 h, following which, non-denatured, solubilized 
cell membrane extracts were prepared as described in Materials and Methods. 
Immunoprecipitation was performed on extracts using monoclonal antibodies 
recognizing integrin !1 (panel a) and laminin #1 (panel b). Subsequently, Western 
blotting analysis was performed using antibodies recognizing laminin #1 (panel a) and 
integrin !1 (panel b). Arrows indicate the presence of a co-immunoprecipitated protein.   
D. PSC were isolated from D4 pregnant uteri and attached for 3 h. Subsequently, cells 
were treated with growth medium containing either BSA (100nM) or echistatin (Echi.), 
(100 nM). After 48 h and 72 h, cells were fixed and subjected to immunofluorescence 
using Alexa-fluor-phalloidin to label F-actin.  
E. Real-time PCR analysis of PRP mRNA levels in BSA and echistatin-treated PSCs.   
F. PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then 
transfected with siRNA (40 nM) targeted against a scrambled, non-coding sequence 
(siCTRL) or integrin !1 (siINTb1) as described in Materials and Methods. After 48 h, total 
RNA was collected and real-time analysis was conducted using primers specific for 
integrin !1, PRP and ALP. Fold changes indicate gene expression levels in siLAMC1-
treated PSCs relative to siCTRL-treated PSCs. 
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FIG. 3.7. 
 
          
 
 
Figure 3.7. Focal Adhesion Kinase (FAK) activation is controlled by laminin !1 
during stromal differentiation. 
 
PSC were isolated from D4 pregnant uteri and attached for 3 h. Cells were then 
transfected with siRNA (20 nM) targeted against a scrambled, non-coding sequence 
(siCTRL) or laminin !1 (siLAMC1) as described in Materials and Methods.  
 
A. After 48 h transfection with siCTRL or siLAMC1, cells were fixed and subjected to 
immunofluorescence using antibodies recognizing phosphorylated Tyr397-FAK. DAPI-
stained nuclei are shown in blue. 
 
B. Whole-cell lysates were prepared from PSC isolated from D4 pregnant uteri and from 
siRNA-transfected PSC after 24, 48 and 72 h of E and P treatment. Protein levels of 
laminin !1, phosphorylated Tyr397-FAK, ER" and calnexin were analyzed by Western 
blotting using specific antibodies. 
 
A 
B 
Phospho-FAK (Y397) 
siCTRL      siLAMC1 
Figure 6 
p-FAK (Y397) 
D4    24   48   72    24   48    72 
siCTRL   siLAMC1 
ER! 
Lamc1 
Calnexin 
! ""#!
 
FIG. 3.8. 
    A 
            
B                                                     
 
C 
       
 
Figure 3.8. Co-culture of pre-implantation blastocysts with uterine stromal cells 
 
A. Schematic representation of the experimental strategy utilized to isolate and co-
culture pre-implantation blastocysts and uterine stromal cells.  
 
B. Pre-implantation blastocysts (panel i) and PSCs were harvested from D4 pregnant 
uteri as described in the Materials and Methods. Blastocysts were placed onto a bed of 
PSCs (panel ii) and cultured together for durations of  21 h (panel iii), 45 h (panel iv), 51 
h (panel vi) and 80 h (panel v). Live-cell images were captured at each timepoint. 
 
C. Blastocyst and PSCs were co-cultured for 48 h (panel a), 72 h (panel b) and 96 h 
(panel c), fixed and subjected to immunofluorescence using an antibody recognizing 
cytokeratin (CK). DAPI-stained nuclei are shown in blue. Migrating trophoblasts are 
indicated by arrows.  
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FIG. 3.9. 
 
  
 
 
Figure 3.9. Embryo invasion into decidual cells is controlled by the stromal 
basement membrane. 
 
Blastocysts were isolated from D4 pregnant uteri and cultured for 48 h on PSCs 
(E+DEC), glass alone (E only), MEFs (E+undiff. MEF), laminin-1-coated glass 
(E+laminin-1) and matrigel-coated glass (E+matrigel). Bars represent the area of embryo 
outgrowth, which was determined using Image J software as described in Materials and 
Methods. 
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Figure 3.10. Embryo invasion into decidual cells is controlled by C/EBP!  and the 
laminin "1-containing ECM 
 
A. Blastocysts and PSCs were harvested from D4 pregnant uteri. PSCs were then 
transduced with adenoviral particles carrying either an empty vector (Ad-CTRL) or a 
vector expressing a dominant negative mutant of C/EBP!, A-C/EBP (Ad-DN) for 24 h. 
After adenovirus removal, blastocysts were placed on Ad-CTRL-treated PSCs (panel a) 
or Ad-DN-treated PSCs (panel b). Cells were fixed and subjected to 
immunofluorescence using an antibody against cytokeratin (CK). DAPI-stained nuclei 
are shown in blue. Area of embryo outgrowth on PSCs was determined using ImageJ 
software as described in Materials and Methods (panel c) and is indicated by dashed 
line. DEC, decidual cells.    
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Figure 3.10. continued: 
 
B. Blastocysts and PSCs were isolated from D4 pregnant uteri. PSCs were then 
transfected with siRNA (40 nM) targeted against a scrambled, non-coding sequence 
(siCTRL) or laminin !1 (siLAMC1) as described in Materials and Methods. After siRNA 
removal, blastocysts were placed on siCTRL-treated PSCs (panel a) or siLAMC1-treated 
PSCs (panel b). Cells were fixed and subjected to immunofluorescence using an 
antibody against cytokeratin (CK). DAPI-stained nuclei are shown in blue. Area of 
embryo outgrowth was determined using ImageJ software as described in Materials and 
Methods (panel c) and is indicated by dashed line. DEC, decidual cells. 
 
C. Real-time PCR analysis of mRNA levels of Lamc1, ALP, PRP, PR and C/EBP" using 
total RNA isolated from siCTRL or siLAMC1-transfected PSCs, prior to co-culture with 
blastocysts.   
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CHAPTER 4 
 
 
 
 
CREATION AND ANALYSIS OF MUTANT MICE LACKING UTERINE 
LAMININ !1 (LAMC1) TO ADDRESS THE ROLE OF LAMININ-CONTAINING 
ECM DURING PREGNANCY 
 
 
4.1. ABSTRACT 
 
During implantation, the uterine stromal tissue undergoes significant remodeling and 
synthesizes a unique basal lamina-like ECM containing laminins, collagen IV and other 
ECM proteins. Laminin !1 helps drive the polymerization of other laminin subunits and 
catalyzes the assembly of the basal lamina, underlining its critical participation in this 
cellular structure. We have previously shown in Chapter 3, using in vitro mouse culture 
systems, that laminin !1 synthesis is regulated by the important decidual factor, C/EBP". 
Furthermore, production of laminin !1 by uterine stromal cells is vital for their ability to 
enter differentiation and acquire a decidual phenotype. In order to address the role of 
laminin !1 in the uterine remodeling process, we created a mutant mouse model in which 
the laminin !1 gene function was conditionally ablated by the use of the loxP/Cre 
strategy. Mice carrying loxP inserts flanking an essential exon of laminin !1 
(Lamc1flox./flox) were crossed with progesterone receptor (PR)-Cre transgenic mice to 
generate laminin !1-null female mice (Lamc1d/d). We confirmed that laminin !1 gene 
expression was specifically extinguished in uterine stromal cells of Lamc1d/d mice during 
early pregnancy (day 6). In an ongoing breeding study, - Lamc1d/d female mice (n=10) 
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were mated with wild type males and found to be subfertile in comparison to Lamc1flox/flox 
mice. - While certain of the Lamc1d/d mice became pregnant and produced a reduced 
number of pups per litter, a majority of mutants failed to give birth despite successful 
mating. These results indicated that laminin !1 plays an important role in the uterus 
during implantation. Future efforts will be directed toward understanding the precise 
nature of the reproductive defect in laminin !1-null mice.  
    
 
4.2. INTRODUCTION 
 
During embryo implantation, an intricate relationship is established between the maternal 
and embryonic tissues. This interaction relies on an intimate association of endometrial 
epithelial and stromal cells with the blastocyst proper thereby permitting bi-directional 
crosstalk between the two tissues. The ability of the uterine tissue to support and 
modulate embryo invasion is a carefully coordinated process requiring the participation 
of the steroid hormones estrogen (E) and progesterone (P). As a result of their regulation 
of endometrial proliferation and differentiation, E and P play a pivotal role in 
coordinating the events surrounding implantation (1). A key maternal event, known as 
decidualization,  is triggered by embryo implantation (2-4). Decidualization is a cell 
differentiation process whereby stromal cells undergo cellular remodeling to form a 
transient, highly specialized tissue that modulates survival and growth of the fetus. Many 
studies have suggested that the production and paracrine functions of numerous growth 
factors, cytokines, and hormones in the decidua are required for the induction of the 
embryonic developmental program (5-7). Simultaneously, several groups have 
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documented the increased peri-cellular deposition of a variety of extracellular matrix 
(ECM) proteins within the decidua (8-10). Among these molecules, laminins, collagen 
type IV and desmin are notable since all three of these molecules are exclusively found in 
the classical basement membrane or basal lamina. In addition to being abundant in 
pregnant uteri (9, 10), laminins, collagen type IV and fibronectin were also synthesized 
by mouse uterine stromal cells cultured in vitro (11, 12). Collectively, these studies raised 
the possibility that the uterine basal lamina-like ECM serves as a platform for tissue 
remodeling and embryo invasion during implantation. However, despite the identification 
of novel ECM components produced by the decidua, the precise role of these ECM 
proteins during early pregnancy remains unclear. In this chapter, we address the role of 
the laminin-containing ECM in controlling decidualization and embryo implantation in 
vivo. 
 
The basement membrane is an intricate structure that controls  the interactions 
between cells and their microenvironments,  providing a local source of growth factors 
and cytokines to cells (13). Laminins, a large family of glyoproteins, are vital to the 
biological functions of the basement membrane and the basal lamina in many different 
mammalian tissues and organs. The functions of this multi-molecular structure largely 
depends on the self-polymerization of laminin subunits and the subsequent recruitment of 
other ECM molecules such as collagen IV and nidogen by the laminins (13-16). Latest 
reports indicate that at least 15 laminin heterotrimers can be derived from five !, three " 
and 3 # subunits (13, 14, 16).  Of these, laminin #1 is especially important because it is 
found in 10 out of the 15 trimers. Furthermore, mutations in the Lamc1 gene caused early 
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lethality in developing embryos due to a failure in embryonic basement membrane 
formation (16). Additionally, a study by Murray et. al. showed that embryoid bodies 
differentiated from Lamc1-null mice lacked appropriate tissue organization, leading to 
fundamental developmental defects that inhibit embryo growth (18). Mutations in two 
other laminin genes, laminin !1 (Lama1) and laminin "1 (Lamb1), were created using a 
gene-trap method and displayed embryonic defects in Reichert’s membrane formation 
and basement membrane formation, respectively (19). Collectively, these studies 
underline the importance of all three laminin genes for fetal survival and development. 
Furthermore, these studies necessitate the creation of transgenic mouse models in which 
the functions of Lamc1, Lama1 and Lamb1 can be conditionally ablated to understand 
their time- and tissue-specific functions. A recent study by Chen et. al. utilized a 
LoxP/Cre strategy to ablate Lamc1 functions in Schwann cells and uncovered a novel 
role for this ECM protein in Schwann cell function.   
 
Recent efforts in our lab have identified the steroid hormone-regulated 
transcription factor C/EBP! as a critical regulator of endometrial function and laminin 
synthesis in the stromal compartment (20-23). Using a DNA microarray approach, we 
identified several putative targets of C/EBP! action in uterine stromal cells among which 
a prominent group of genes encoded ECM proteins (Wang, W. et. al, unpublished). In 
Chapter 3, the functions of laminin subunits "1 and #1 were closely examined, using in 
vitro approaches, and the results indicated a close relationship between C/EBP" and 
laminin #1 function during decidualization. These studies suggested that C/EBP!-
regulated laminin #1 initiates formation of a unique basal lamina-like ECM that supports 
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decidualization and initiates a dialogue between maternal decidual cells and the invading 
embryo during implantation. In support of our findings, present literature is suggestive of 
a major role of uterine ECM molecules in modulating embryo growth and survival (5, 24, 
25).  We propose that the assembly of a uterine basal lamina-like ECM network 
containing laminin !1 provides the necessary environmental setting in which the stromal 
tissue differentiates and supports embryo invasion. To advance our understanding of the 
role of laminin !1 in implantation, we developed a mouse model in which we selectively 
ablated laminin !1 gene function using a PR-driven Cre recombinase. We and others 
have successfully used this strategy to understand the role of a wide variety of genes 
involved in decidualization (26-28). Briefly, mice harboring ‘floxed’ alleles of laminin !1 
(Lamc1f/f) were crossed with transgenic PR-Cre mice to generate laminin !1-deficient 
mice. The PR promoter attains maximal activity in the uterine stroma during the early 
post-implantation stages of pregnancy, inducing Cre recombinase and effectively 
eliminating expression of laminin !1 in these cells. In this chapter, we describe the 
creation of the laminin !1-null mice and the ongoing breeding studies using these mice.  
 
 
4.3. MATERIALS AND METHODS 
 
Animal handling and tissue collection 
 
All experiments involving animals were conducted in accordance with the National 
Institutes of Health standards for the use and care of animals. The animal protocols were 
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approved by the University of Illinois Institutional Animal Care and Use Committee. For 
mating studies, Lamc1flox/flox and Lamc1flox/floxPR-Crecre/+(Lamc1d/d) mice were housed 
with wild type C57/BL6 mice (Charles River). The presence of a vaginal plug after 
mating was designated as the first day of pregnancy. Animals were sacrificed at various 
days of pregnancy for uterine tissue collection and for primary stromal cell isolation.  
 
Generation of conditional laminin !1-null mice 
 
Conditional laminin !1-null mice (Lamc1flox/flox PRcre/+) were generated by crossing 
laminin !1-floxed mice (a gift from Z. Chen and S. Strickland), (29) with PR-Cre knock-
in mice (25). Briefly, female homozygous laminin !1-floxed mice (Lamc1flox/flox) were 
mated with male homozygous PR-Cre mice (PRcre/cre) to produce offspring (Lamc1flox/+ 
PRcre/+) that are heterozygous for both mutations. These heterozygous mice (Lamc1flox/+ 
PRcre/+) were then bred with each other or with homozygous laminin !1-floxed mice 
(Lamc1flox/flox) to produce conditional mutant mice with the genotype laminin !1flox/flox 
PRcre/+ (Lamc1d/d). Additionally, homozygous mice obtained from the second cross 
(Lamc1flox/floxPRcre/cre) were bred with homozygous laminin !1-floxed mice (Lamc1flox/flox) 
to produce conditional mutant mice (lamc1d/d). In these mice, Cre-mediated excision of 
floxed laminin !1 led to a null mutation of this gene in PR-expressing tissues. Genomic 
DNA isolated from tail biopsy samples was used for PCR screening to verify the 
genotypes of mice. The primer sequences used were P1 (5’-
CTCAGAGCTGGCTTCTCACAT-3’) & P2 (5’-GATTTTCAAAGAAGCAGAGTGTG-
3’). The PR-Cre-mediated excision of floxed laminin !1 alleles in Lamc1d/d!mice was 
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assessed by PCR analysis of genomic DNA isolated from primary stromal cells of 
pregnant uteri (day 6).  
 
Primary uterine stromal cell isolation 
 
Primary uterine stromal cells were harvested from pregnant uteri on day 6 of pregnancy 
as previously described in Chapter 3.  
 
Real-time PCR analysis 
 
Total RNA was isolated from primary stromal cells of pregnant uteri by standard Trizol-
based protocols and converted to cDNA as described previously in Chapter 2. The cDNA 
was amplified by real-time PCR to quantify gene expression using gene-specific primers 
and SYBR® Green (Bio-Rad Laboratories). As a loading control, the expression level of 
36B4 gene, which encodes a ribosomal protein, was determined. For each treatment, the 
mean threshold cycle (Ct) and standard deviation were calculated from Ct values 
obtained individually from 3 to 4 replicates of that sample. Each sample was subjected to 
three independent real-time PCR trials. Fold change was derived from the mean Ct values 
as described previously in Chapter 2. ANOVA single factor analysis was conducted on 
the grouped means to determine statistical significance at a significance level of P<0.05.  
 
The real-time PCR primer sequences are: laminin !1, GATGACGCCGACCAGGAC 
(forward) and GCTGAGGAGGCTGCTGAC (reverse); laminin !1:exon 2, 
CCGAGTGCCTACAACTTTGA (forward) and GCTGGCATGTCCGTTACATT 
(reverse); laminin !2 TGCCACGCCTCTGCCGACTTC (forward) and 
! "##!
ACCGCCTTCCAACCATCCACATCC (reverse); PR, AGCCAGCCAGAGCCCACAG 
(forward) and CCCACAGGTAAGCACGCCATAG (reverse); 36B4, 
CTGCTGCCACCACTGCTG (forward) and TCCTCATCTGATTCCTCCGACTC 
(reverse). 
 
Immunohistochemistry 
 
For all proteins labeled, uterine sections were obtained, flash frozen and embedded in 
OCT. Cryosections were taken at 10 µm and subjected to immunostaining. Uterine 
sections were fixed using a 10% formalin solution (Sigma) and then blocked using a 5% 
solution of normal donkey serum (Jackson Immunoresearch) in PBS. Sections were 
incubated with the following primary antibodies diluted in blocking solution (0.25% 
BSA, 0.3% Triton X-100, sterile PBS) overnight at 4ºC: laminin !1 (Abcam) and pan-
laminin (Sigma). The sections were washed and incubated with biotinylated secondary 
antibodies  (Jackson Immunoresearch  Laboratories  Inc.) for  60  min followed  by 
incubation  with  streptavidin-conjugated  horseradish  peroxidase  (Histostain  Kit; 
Zymed  Laboratories Inc.) for  45  min. Sections  were  stained  with  AEC  solution  
(Zymed Laboratories Inc.) and counterstained with Mayer’s Hematoxylin (Sigma). 
Immunofluorescence staining was performed by incubating sections with Cy3-
conjugated secondary antibodies (Jackson Immunoresearch Laboratories). The 
counterstaining was done using 4’,6’-diamidino-2-phenylindole (DAPI; Invitrogen Inc.). 
Stained sections were mounted in Vectashield fluorescence mounting media ( V e c t o r  
L a b o r a t o r i e s ) .  Negative controls included incubation with donkey serum and 
omission of the primary antibody for all samples. 
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4.4. RESULTS 
 
Expression of laminin !1 in the uterus during early pregnancy. 
 
We monitored the expression of laminin !1 in wild type pregnant uterine tissue and found 
that this ECM molecule is robustly expressed in various compartments of the uterus 
throughout early pregnancy. On day 5 of pregnancy, soon after embryo implantation, 
laminin !1 is expressed in the uterine stroma and deposited in the pericellular spaces 
between stromal cells (Fig. 4.1, panel a & d). We also observed high levels of laminin !1 
in the epithelial basement membrane and the basement membrane of developing 
endothelial blood vessels.  Additionally, high levels of laminin !1 were observed in the 
myometrial compartment of the uterus.  As pregnancy advanced to days 6 -8, laminin !1 
expression intensified in the primary decidual zone of the uterus surrounding the 
implanted embryo. During this time, the laminin !1 expression was highly organized and 
appeared to radiate in a complex, network-like fashion towards the secondary decidual 
zone (Fig. 4.1, panel b, c, e & f). The high levels of laminin !1 in the myometrium were 
maintained on days 6 and 8. The laminin !1 expression was also localized in endothelial 
basement membrane on day 8, which is in agreement with previous reports about 
endothelial laminin expression. The close spatio-temporal association of laminin !1 
expression with the progression of decidualization strongly suggests that the laminin !1-
containing basal lamina is important for this biological transformation.  
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Generation of mice with uterine stromal cell-specific excision of the laminin !1 gene.  
 
 
It was previously discovered that mice carrying a global laminin !1-null mutation die at 
the embryonic stage due to failure of basement membrane formation early in 
embryogenesis (17). To address the functional role of laminin !1 during early pregnancy 
in adult mice, we employed the LoxP/Cre strategy to generate a conditional mutant 
lacking the expression of this ECM protein in stromal cells of the pregnant uterus. We 
achieved the deletion of laminin !1 gene by crossing female mice harboring a “floxed” 
laminin !1 gene (29) with PR-Cre (26) male mice in which the gene encoding Cre is 
inserted at the PR gene locus and under the control of the PR promoter. When the 
resulting laminin !1flox/flox PRcre/+ (Lamc1d/d) female progenies were bred with WT males 
of the same background (C57/BL6), the expression of Cre, which is controlled by the 
promoter regions of the endogenous PR gene, was maximally induced during early 
pregnancy. This led to the Cre-mediated excision of the “floxed” laminin !1 gene in PR-
expressing uterine cells, as evidenced by the significant loss of laminin !1 mRNA 
expression in the PR-positive stromal cells of the conditional mutant mice during early 
pregnancy (day 6) (Fig. 4.2 A). The excision of laminin !1 did not produce any changes 
in PR mRNA levels (Fig. 4.2 B). Additionally, we did not observe any compensatory 
increase in the mRNA levels of laminin !2, a related laminin ! subunit (Fig. 4.2 C). 
Immunohistochemical analysis confirmed the Cre-mediated excision of laminin !1 in 
uterine stromal cells near the site of embryo implantation, consistent with the fact that 
these cells express high levels of PR during pregnancy (Fig. 4.2 D, panels d-f). In 
contrast, excision of the “floxed” laminin !1 gene was not detected in uterine endothelial 
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basement membrane or the embryonic basement membrane, where PR is not expressed, 
indicating the cell-specific nature of the conditional mutation (Fig. 4.2 D, panel e, 
arrows). We also noted that laminin !1 expression was significantly reduced in the 
myometrium of pregnant uteri (Fig. 4. 2D, panel f).  
 
A limited breeding study was initiated in September 2009 in which female mice lacking 
laminin !1 exhibited reduced fertility (Table 1). Our studies indicated that out of ten 
Lamc1d/d females placed in the breeding program, four (40%) became pregnant and 
delivered litters. Only two of these litters survived beyond the first two days of their 
birth. Interestingly, the four mice, which had delivered pups in their first pregnancy, 
never produced a second litter. They exhibited normal mating behavior but failed to give 
birth. Additionally, our analysis revealed that six out of ten female mice that were 
originally placed in the breeding program (60%) never gave birth despite mating 
normally with WT males. Overall, mice carrying a conditional ablation of laminin !1 
(Lamc1d/d) gave birth to approximately 95 % lesser number of pups than Lamc1flox/flox 
mice (15/10 vs. 81/8).   
 
 
4.5. DISCUSSION AND ON-GOING STUDIES 
 
During embryo implantation, the uterine stroma synthesizes a unique basal lamina-like 
ECM composed of laminins and collagen IV that assembles into a well-organized 
pericelluar network (3, 5, 9). Although the precise function of this ECM is presently 
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unclear, it is thought to be important in supporting decidualization and embryo invasion 
(5). In chapter 3, we made the significant observation that the expression of laminin !1, 
an important component of the basal lamina-like ECM, is directly regulated by the 
transcription factor C/EBP" during decidualization. Furthermore, we have shown that the 
function of laminin !1 is important for stromal differentiation and embryo invasion in 
vitro. The next challenge is to evaluate the importance of laminin !1 function in utero by 
employing a conditional laminin !1 knockout mouse model. In this section, we discuss 
our efforts towards this aim and future strategies for defining the phenotype of laminin 
!1-null mice.   
 
The spatio-temporal expression of laminin !1 closely overlaps with the decidualization 
process in uterine stromal compartment. When we examined laminin !1 expression on 
days 5 through 8 of pregnancy, we found increasing levels of laminin expression in the 
stromal cells underlying the luminal epithelium and surrounding the implanted embryo. 
The peri-cellular deposition of the laminins in the stromal compartment coincides with 
the progress of decidualization, strongly suggesting that the laminin !1-containing ECM 
has a major function in the differentiation process. Additionally, high levels of laminin !1 
were observed in the uterine myometrial compartment during early pregnancy. The 
functional significance of myometrial laminin expression is presently unclear.  
 
We observed that only a small subset (20%) of laminin !1-deficient female mice gave 
birth to healthy offspring, indicating that female mice lacking this gene are sub-fertile 
(Table 1). Immunohistochemical assays revealed that the expression of laminin !1 
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mRNA and protein was efficiently ablated in uterine stroma and myometrium of 
Lamc1d/d mice at an early stage of pregnancy (Fig. 2). The presence of laminin !1 in the 
basement membrane of the endothelial cell network is consistent with the fact that these 
blood vessel structures do not express PR (30), thereby avoiding the Cre-mediated 
excision of laminin !1. It was also noted that laminin !1 is highly expressed in the 
embryonic basement membrane of both Lamc1flox/flox and Lamc1d/d mice, in accordance 
with previous findings (19). Furthermore, the presence of implanted embryos on day 6 of 
pregnancy in laminin !1-null uteri indicated that embryo attachment to the uterine wall 
was not affected by this mutation. Taken together, our preliminary observations are 
strongly suggestive of a reproductive failure in laminin !1-null mice. The ongoing efforts 
are to identify the precise nature of the reproductive defect in these mice and to identify 
the molecular mechanisms by which laminin !1 controls uterine function.  
 
In order to pinpoint the mechanisms underlying the reproductive defect in laminin !1-null 
mice, we are assessing the integrity of the female reproductive axis. The ovarian function 
in laminin !1-null mice will be analyzed through the use of superovulation experiments 
conducted with mutant mice. Based on our preliminary findings that a subset of laminin 
!1-null mice gave birth, we predict that ovarian function is preserved in these mutants. 
Additionally, we examined whether the adult laminin !1-null females (n=5) displayed 
estrous cycling and found that these mice progressed normally through the estrous cycle 
stages (data not shown). If ovarian function is found to be intact in these mice, a detailed 
and systematic analysis of developmental landmarks in pregnant laminin !1-null mice 
would have to be conducted. For example, an initial strategy would involve the 
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harvesting of uterine tissue from Lamc1flox/flox and Lamc1d/d on days 8, 10, 12, 18 and 21 
of pregnancy. These time points would inform us about important stages of the uterine 
remodeling process during pregnancy, including embryo attachment, embryo invasion, 
decidualization, neo-vascularization, placentation and parturition. Using these 
approaches, we would eventually understand the contribution of the laminin !1-
containing ECM to the uterine remodeling process.    
 
 
4.6. ACKNOWLEDGEMENTS 
 
The authors wish to thank Dr. Zu-Lin Chen and Dr. Sidney Strickland for generously 
providing the floxed laminin !1 transgenic mice; Elizabeth Hunt and Katya Dribinsky for 
genotyping assistance; Dr. Quanxi Li and Mary Laws for helpful discussions and 
technical expertise. This work was supported by the Center for Research in Reproduction 
and Infertility, UIUC supported by Eunice Kennedy Shriver NICHD/NIH. 
 
 
 
 
 
 
 
 
! "#$!
4.7. FIGURES, TABLES AND LEGENDS 
 
FIG. 4.1 
 
 
Figure 4.1. Induction of Laminin !1 expression in uterine stromal cells 
during implantation 
 
Frozen uterine tissue sections were collected on days 5 (panels a, c), 6 (panels b, e) 
and 8 (panels c, f) of pregnancy and subjected to immunohistochemical analysis using 
a rat monoclonal antibody against laminin !1. Positive immunfluorescent staining for 
laminin !1 is indicated in red and DAPI-stained nuclei are indicated in blue. Panels a-c, 
lower magnification areas. Panels d-f, higher magnification views of the images in 
panels a-c.  
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FIG. 4.2 
 
 
Figure 4.2. Loss of laminin !1 expression in the uterine stromal cells of Laminin 
!1-conditional knockout mouse 
 
Lamc1flox/flox mice and Lamc1d/d mice were subjected to timed matings as described in 
the Materials and Methods. Mice were sacrificed and uteri collected on day 6 of 
pregnancy.  
A. Primary stromal cells were harvested from pregnant uterine tissue as described in 
Materials and Methods. Real-time PCR analysis was employed to measure gene 
expression of laminin !1 in Lamc1d/d mice relative to Lamc1flox/flox mice  
B. Real-time PCR analysis of PR mRNA levels in Lamc1flox/flox and Lamc1d/d mice.  
C. Real-time PCR analysis of laminin !2 mRNA levels in Lamc1flox/flox and Lamc1d/d mice. 
D. Uterine cross sections from pregnant mice (day 6) stained with an antibody 
recognizing laminin !1. In Lamc1flox/flox mice, laminin !1 expression was abundant 
throughout the uterine stromal compartment (panels a-c). In contrast, laminin !1 
expression was efficiently ablated in the uterine stromal cells of laminin !1-null mice 
(panels d-f). Laminin !1 expression in the endothelial and embryonic basement 
membranes was intact in laminin !1-null uteri and is indicated by black arrows (panel e).  
Myometrial expression of laminin !1 is also ablated in Lamc1d/d mice and is indicated by 
two-headed arrows (panels c & f). E denotes the implanted embryo.  
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TABLE 4.1 
 
Genotype Number of Mice 
Number of 
litters 
Number 
of healthy 
pups 
Number of 
pups/mouse 
Lamc1flox/flox 11 18 98 8.9 
Lamc1d/d 10* 2‡ 15 1.5 
* 10 mice were put into the breeding program, 6 did not give birth 
‡ Out of 4 litters born, 2 litters died within 2 days of birth 
 
Table 4.1. Impact of Laminin !1 ablation on female fertility 
 
Lamc1flox/flox and Lamc1d/d mice were placed into a six-month breeding study to assess 
female fertility.  
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CONCLUSIONS 
 
 
 
Embryo implantation is a critical biological program that determines a successful 
pregnancy. This important event can be dissected into the pre-implantation preparation of 
the uterine lining and the post-implantation uterine remodeling process, involving stromal 
decidualization and neo-vascularization. Through the efforts of many groups, the 
mechanisms by which the steroid hormones E and P control these landmark events are 
beginning to be understood. In this dissertation, the actions of an important steroid 
hormone-regulated transcription factor, C/EBP!, have been analyzed through the use of a 
C/EBP!-null mouse model and an in vitro primary cell culture system.  
 
Our studies established an essential role for C/EBP! in the E-dependant growth and 
preparation of the uterine epithelial lining. C/EBP! performs its important functions in 
the epithelium by controlling the DNA replication step of the cell cycle. By allowing the 
epithelial cells to undergo proper cell division in response to the hormone, it preserved 
genomic integrity and prevented apoptosis of these cells. Our in vitro studies, using a 
primary stromal cell culture model, established that C/EBP! is also a major regulator of 
uterine stromal differentiation (decidualization). It does so by controlling the formation of 
a unique laminin-containing ECM. The laminin family member, laminin "1 was shown to 
be directly regulated by C/EBP! and is a critical component of this unique ECM. The 
basal lamina-like ECM modulates integrin-dependant cell signaling and differentiation. 
By modeling uterine events employing embryo-stromal co-cultures, we identified a 
laminin-dependent mechanism by which embryos can invade into uterine stromal cells. 
! "#$!
Finally, we set out to define a role for the laminin-containing stromal ECM in vivo by 
creating a laminin !1-conditional knockout mouse model. Based on our preliminary 
results and the ongoing studies with this mouse model, the role of the laminin-containing 
uterine ECM will be further clarified.  In conclusion, the studies presented in this 
dissertation have provided important contributions to the overall understanding of how 
the steroid hormones control the growth and differentiation of the uterus to regulate 
female fertility. Furthermore, the knowledge gained about the proliferative role of 
C/EBP" during uterine epithelial growth may be of clinical relevance as it may help us to 
understand the role of this factor in endometrial cancer. 
! "#$!
APPENDIX A 
 
SUMMARY OF GENES UPREGULATED IN E-TREATED C/EBP!-NULL 
UTERINE EPITHELIAL CELLS 
 
 
 
TABLE A.1. Summary of genes upregulated in 18 h E-treated C/EBP!-null 
uterine epithelial cells 
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TABLE A.1 CONTINUED – 
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